Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025

152 companies Today

Accel Entertainment, Inc.

ACEL Q1 2026

Reported: 2026-05-07

Accel Entertainment's shares dropped 6.9% following the release of Q1 results despite reported revenue and EBITDA growth, reflecting investor disappointment primarily linked to cautious outlook comments and potential margin pressure in a challenging macro environment.

Key takeaways

Q1 revenue reached a record $352 million, up 9% year-over-year.
Adjusted EBITDA increased 9% to $54 million, driven by solid performance across core and developing markets.
Illinois, the largest market, grew revenue by 6% with improved location hold per day (+9%), though the mature state market shows signs of limited terminal growth.
Developing markets showed strong top-line momentum, including Nebraska (+57% revenue), Georgia (+43%), and Nevada (locations +27%).
Management highlighted macroeconomic uncertainty and inflation risks, signaling cautious views on near-term consumer demand despite operating leverage and financial flexibility.

Assurant, Inc.

AIZ Q1 2026

Reported: 2026-05-07

Shares declined 1.4% following a solid but somewhat cautious quarter, with the market seemingly tempering enthusiasm amid signs of moderation in overall growth and a conservative outlook for Global Housing's combined ratio and catastrophe assumptions.

Key takeaways

Adjusted EBITDA grew 6% and adjusted EPS increased 9% in Q1, excluding catastrophe events; growth improves to 8% and 12%, respectively, when excluding prior year reserve development.
Global Lifestyle delivered strong double-digit earnings growth, with Connected Living up 18% and Global Automotive rising 23%, driven by client expansions, operational efficiencies, and new AI-enabled initiatives.
Global Housing showed double-digit top-line growth in homeowners and renewed over 5 million loans via long-term lender place contracts; however, the outlook includes a cautious combined ratio target in the low to mid-80s and a $185 million catastrophe assumption for the year.
Share repurchases accelerated given the company’s capital flexibility, reflecting confidence in underlying value despite tempered near-term growth signals.

Astera Labs, Inc. Common Stock

ALAB Q1 2026

Reported: 2026-05-07

Astera Labs shares rallied 6.3% after the company reported broad-based revenue growth led by strong execution in PCIe Gen 6 products and expanding design wins in AI fabric switches, signaling investor confidence in its AI infrastructure opportunity and robust demand outlook.

Key takeaways

Q1 revenue reached $308 million, up 14% sequentially and 93% year-over-year, reflecting diversified growth across signal conditioning and fabric switch segments.
PCIe Gen 6 products contributed over one-third of total revenue, demonstrating portfolio maturity with millions of ports shipped to date.
Scorpio X-Series AI fabric switches transitioned from preproduction to initial volume ramp, with a new 320-lane flagship product designed to enhance AI platform performance via hardware-accelerated in-network compute.
Expansion of Scorpio product lines and deepening software integration through COSMOS enhance competitive moats and appeal to hyperscalers and enterprise infrastructure builders.
The company anticipates continued strong revenue growth into 2026 and 2027, driven by secular AI spending trends, increasing silicon dollar content in AI racks, and broadening customer partnerships.

Alight, Inc.

ALIT Q1 2026

Reported: 2026-05-07

Alight, Inc. shares rose 15.6% following the earnings release, primarily driven by better-than-expected project revenue growth and improved partner revenue performance that surprised positively despite recurring revenue pressure.

Key takeaways

Q1 2026 revenue totaled $534 million, with project revenue up 29% year-over-year, offsetting a 4% decline in recurring revenue.
Adjusted EBITDA reached $104 million, with margin decline limited to 200 basis points due to strong revenue flow-through and lower-than-expected employee health care costs.
Free cash flow improved 20% from the prior year, totaling $53 million, supporting strong liquidity of over $500 million post-TRA payment.
Leadership highlighted progress in new sales activity and client renewals, alongside significant senior hires aimed at enhancing commercial execution and customer experience.
The company expanded strategic account coverage from the top 100 to top 400 clients, representing over 90% of ARR, to drive retention and pipeline development.

AMC Entertainment Holdings, Inc.

AMC Q1 2026

Reported: 2026-05-07

The stock jumped 13.1% on exceptionally strong adjusted EBITDA and robust box office growth, driven by a 22% surge in the North American box office that surpassed expectations and lifted both domestic and international segments.

Key takeaways

Adjusted EBITDA improved by $96 million year-over-year, marking the best first quarter result since 2019 pre-pandemic.
North American box office revenue increased 22% in Q1, the strongest start since the pandemic began.
International performance notably improved, particularly across AMC's European footprint.
Balance sheet enhancements included refinancing $400 million of debt to 2031, reducing interest expense, and raising $72 million via equity issuance.
Opportunistic asset sales generated $30 million cash in Q1, totaling $54 million from Hycroft Mining holdings, surpassing original investment.

Arista Networks, Inc.

ANET Q1 2026

Reported: 2026-05-07

Arista's shares fell sharply by 14.8% following earnings, driven primarily by a notably cautious outlook and evident deceleration in key growth metrics despite ongoing strength in AI-driven product innovation and market share gains.

Key takeaways

The market punished Arista for guidance that implied slower growth ahead, overshadowing product momentum.
While Arista claimed leadership in high-speed switching (>10GbE), tangible financial drivers behind this growth were not highlighted.
AI networking deployments have expanded, but concrete revenue impact or acceleration signals were not clearly communicated.
Enterprise business showed some strength, particularly with VeloCloud integration, but this was insufficient to offset investor concerns about margin and overall growth trajectory.
Innovation in optics (XPO form factor) and AI fabrics points to a strong product roadmap, but current execution concerns and near-term demand weakness weighed on the stock.

Aurora Innovation Inc. Class A Common Stock

AUR Q1 2026

Reported: 2026-05-07

Shares rose 9.3% as Aurora's clear roadmap toward scaling its autonomous trucking fleet and meaningful cost reductions in hardware drove investor enthusiasm, signaling confidence in execution and market expansion despite limited near-term financial details.

Key takeaways

Aurora is preparing to launch its second-generation commercial hardware kit in Q2, designed for 1 million miles of operation and featuring a 50%+ reduction in hardware costs.
The new hardware includes FirstLight, a proprietary long-range FMCW lidar with a 1-kilometer range, doubling competitor performance and enhancing safety reaction time to more than 34 seconds at highway speeds.
Expansion accelerated with 12 distinct routes now in operation, including new bidirectional service between Dallas-Laredo and Dallas-Oklahoma City.
Collaboration with Hirschbach targets scaling to 500 autonomous trucks under a Driver-as-a-Service model, representing potential multiyear revenues in the hundreds of millions starting 2027.
The existing fleet demonstrated strong utilization, for example Werner’s trucks averaging over 4,000 miles per week with 100% on-time performance and zero Aurora Driver-attributed collisions.

Axon Enterprise, Inc.

AXON Q1 2026

Reported: 2026-05-07

Axon's shares jumped 12.2% after reporting broad-based strength in customer adoption and product demand, signaling investor confidence in its accelerating innovation cycle and expanding market reach.

Key takeaways

Recorded strongest ever Q1 performance across revenue, bookings, and new product introductions.
Set first quarter booking records in U.S. public safety, international, and enterprise segments.
Sustained TASER growth contributed meaningfully to top-line momentum.
Indications of broad demand with no reliance on a single product, geography, or segment.
Management highlighted a shift to faster, AI-powered, integrated solutions driving customer adoption.

Azenta Inc.

AZTA Q2 2026

Reported: 2026-05-07

Azenta's shares dropped 24.5% following the Q2 report as investors were disappointed by organic revenue decline, margin compression, and a cautious full-year outlook amid execution challenges and soft demand, particularly in North America.

Key takeaways

Organic revenue decreased 3% year-over-year in Q2, driven by weakened demand in North America and competitive pressures in Multiomics.
Adjusted EBITDA margin fell to 5.4%, below expectations, reflecting lower volumes and operational inefficiencies.
Continued strength was seen in recurring revenue areas, including sample repository solutions, product services, consumables, and instruments.
Softness persisted in automated and cryogenic store systems, with ongoing quality remediation delays expected to extend into Q3.
Fiscal 2026 guidance was lowered to organic revenue growth between -2% and +1%, with adjusted EBITDA estimated down 125 basis points to flat, citing prolonged capital deployment constraints and cautious demand.

The Brink's Company

BCO Q1 2026

Reported: 2026-05-07

Brink's shares rose 3.3% following a quarter that beat expectations on sustained strong growth in higher-margin ATM Managed Services and Digital Retail Solutions, alongside margin expansion and record cash flow generation.

Key takeaways

Q1 revenue increased 10% yoy, with 4.5% organic growth driven by 15% growth in AMS/DRS, continuing its 13-quarter streak of double-digit expansion.
EBITDA margin expanded 10 basis points to 17.3%, supported by over 100 basis points of margin improvement in North America and Rest of World, and 240 basis points in Europe.
Trailing 12-month EBITDA exceeded $1 billion for the first time, reflecting more than $200 million growth since end-2022.
Free cash flow topped $0.5 billion on a trailing 12-month basis, with a 50% conversion rate from EBITDA and over $12 per share generated in Q1 alone.
The company reaffirmed its 2026 outlook for mid-single-digit organic growth and margin expansion of 30 to 50 basis points, supported by the planned acquisition of NCR Atleos and anticipated cost synergies.

BlackLine, Inc.

BL Q1 2026

Reported: 2026-05-07

BlackLine’s shares dropped 11.6% following earnings as investors reacted negatively to cautious forward guidance and signs of deceleration in key growth metrics, despite solid revenue growth and margin improvements.

Key takeaways

Revenue increased 9.7% year-over-year, demonstrating top-line growth, but the pace appears to be slowing relative to prior trends.
Non-GAAP operating margin improved to 21.6%, showing ongoing operating leverage.
Remaining performance obligations (RPO) grew 18%, driven by longer contract terms linked to the platform strategy.
Platform adoption progressed, with 13% of eligible ARR on Studio360 up from 11% last quarter, and 94% of new bookings landing on platform pricing.
Average new deal size increased by 85% to $162,000, reflecting upselling of platform and strategic products, but overall investor caution suggests concerns around sustainability and guidance.

BillionToOne, Inc. Class A Common Stock

BLLN Q1 2026

Reported: 2026-05-07

BillionToOne’s stock surged 16.3% following an earnings report that impressed investors with outsized revenue growth, significant test volume expansion, and margin expansion, signaling confidence in the company’s high-growth trajectory and innovative product pipeline.

Key takeaways

Total revenue grew 84% year over year, driven by a 44% increase in test volume.
Average selling prices rose 28% to $571 per test, supporting gross margin expansion to 73%, up 9 percentage points year over year.
Cost of goods sold remained controlled at $153 per test despite a higher mix of oncology tests with typically higher COGS.
The company reported a strong profitability profile with a 16% GAAP operating margin and 24% adjusted EBITDA margin.
Recent market developments include the launch of Unity Confirm, a novel noninvasive fetal cell-based confirmation test addressing a critical clinical need, alongside progress on oncology product launches and network coverage expansion to 300 million U.S. lives.

Bruker Corporation

BRKR Q1 2026

Reported: 2026-05-07

Bruker shares jumped 15% after the company delivered better-than-expected bookings growth in key AI-driven segments and reaffirmed its full-year outlook despite ongoing organic revenue challenges and margin pressure.

Key takeaways

Q1 2026 revenue was $823 million, up 2.7% year-over-year, driven by an FX tailwind (4.5%) and acquisitions (2.6%), offsetting a 4.4% organic revenue decline.
The Bruker Scientific Instruments (BSI) segment showed 5% organic revenue decline but offset by high single-digit organic bookings growth, led by AI-driven semiconductor metrology and scientific software/digitization businesses each growing bookings over 20%.
BEST segment reported 3% organic revenue growth and secured approximately $680 million in multi-year orders across research instruments and superconductors.
Non-GAAP gross margin declined to 50% and operating margin to 10.2%, pressured by currency headwinds, although both were still better than expectations.
Non-GAAP EPS of $0.31 declined versus prior year’s $0.47 but beat prior expectations; management expects momentum to return to organic revenue growth in Q2 and beyond.

Dutch Bros Inc.

BROS Q1 2026

Reported: 2026-05-07

Dutch Bros shares declined 6.3% following the quarter, reflecting investor disappointment despite reported revenue growth, likely due to cautious outlook or signals of deceleration not fully addressed in management commentary.

Key takeaways

Total Q1 revenues increased 31%, with adjusted EBITDA up 26%.
The company opened 41 new shops in Q1, ahead of schedule, aiming for 2,029 shops by 2029.
System-wide average unit volumes (AUVs) reached record levels; Texas same-store sales grew nearly 20%.
Converted Clutch Coffee Bar locations are outperforming, generating over 3x pre-conversion volumes.
Despite operational highlights, the stock sell-off suggests questions around the sustainability of growth or margin pressures remain.

Peabody Energy Corporation

BTU Q1 2026

Reported: 2026-05-07

Shares declined 5.9% as investors reacted negatively to the material downgrade in Centurion mine production guidance and associated margin pressure from higher costs, signaling operational challenges and cautious near-term outlook at the key met coal asset.

Key takeaways

Full year Centurion production guidance cut by 1 million tons, down to 2.5 million tons from the prior 3.5 million tons due to extended commissioning delays and slower ramp-up.
Unit costs at Centurion revised higher to a range of $123–$133 per ton, reflecting inefficiencies and remediation efforts impacting margins.
The planned fourth-quarter longwall move at Centurion postponed to early 2027, shifting volumes and production upside to next year.
While Seaborne Thermal volumes, pricing, and costs outperformed expectations, strong LNG prices and geopolitical factors supported thermal coal demand; these positives were overshadowed by met coal segment weakness.
Continued development initiatives into rare earth elements and critical minerals remain early stage with no near-term financial impact.

BorgWarner Inc.

BWA Q1 2026

Reported: 2026-05-07

BorgWarner’s shares ticked up modestly by 1.6% following the Q1 report, reflecting a quarter largely in line with expectations without a clear catalyst to drive a stronger move.

Key takeaways

Reported sales of $3.5 billion with organic net sales down approximately 3% year-over-year, in line with declining market production.
Adjusted operating margin came in at 10.5%, supported by ongoing cost controls despite headwinds from the Battery Energy Systems segment.
Continued momentum in new business awards, including 12 wins across electric motors, turbochargers, and drivetrain technologies, indicating sustained customer trust.
Progress on the turbine generator product for a 2027 launch remains on track, with customer samples delivered and production readiness advancing.
Returned $185 million to shareholders via buybacks and dividends, reflecting disciplined capital deployment amidst a challenging sales environment.

Credit Acceptance Corporation

CACC Q1 2026

Reported: 2026-05-07

Credit Acceptance's stock declined modestly by 0.5% following the earnings release, reflecting investor neutrality amid a mixed quarter marked by moderated declines in loan volume and cautious commentary on the challenging nonprime consumer environment.

Key takeaways

GAAP net income stood at $12.40 per diluted share, with adjusted net income at $10.71 per diluted share for Q1 2026.
Net cash flows from the loan portfolio declined modestly by $9.1 million, or 0.1%, the smallest quarterly reduction in three years.
Consumer loan assignment volume decline moderated from 9.1% to 4.3% year-over-year, though originations still contracted.
Implemented a new company-wide operating system aimed at enhancing operational discipline and decision-making cadence.
Completed workforce reduction of approximately 6% to recalibrate cost structure and improve efficiency while investing in talent to support long-term value creation.

Instacart (Maplebear Inc.)

CART Q1 2026

Reported: 2026-05-07

Instacart’s shares dropped 13.1% post-earnings as investors reacted negatively to cautious signs buried in the commentary around growth drivers and an implied slowdown in momentum despite revenue milestones.

Key takeaways

Gross Transaction Value (GTV) grew 13% year-over-year, surpassing $10 billion for the first time.
Revenue increased 14% year-over-year, breaking the $1 billion quarterly revenue threshold.
Management highlighted improvements in marketplace features and AI integration to enhance customer experience.
Enterprise platform expansion continued, with Storefront Pro adoption by major retailers like ALDI, driving incremental sales lift.
Despite positives, the stock’s steep decline signals investor concern around the pace of growth, profitability sustainability, or caution in forward outlook that was not explicitly optimistic.

The Chemours Company

CC Q1 2026

Reported: 2026-05-07

Shares fell 19.8% as investors reacted to a cautious outlook and a notable operational setback in Advanced Performance Materials (APM), with the Washington Works outage causing significant volume declines and margin pressure despite mixed results in other segments.

Key takeaways

Advanced Performance Materials sales declined due to the Washington Works outage and prior closure of the SPS Capstone line, creating a $25 million adjusted EBITDA headwind.
Thermal and Specialized Solutions (TSS) achieved 22% year-over-year sales growth with record adjusted EBITDA and expanded margins to 33%, driven by strong pricing and volume gains in refrigerants.
Titanium Technologies (TT) faced volume declines in non-Western markets but maintained net sales inline with expectations through disciplined global pricing, surpassing EBITDA targets.
Balance sheet improvements included accelerated sale of Kuan Yin properties and debt repayment, enhancing financial flexibility.
Management highlighted ongoing market uncertainty and emphasized operational flexibility and continued pricing initiatives, signaling a cautious outlook.

CDW Corporation

CDW Q1 2026

Reported: 2026-05-07

Shares fell 19.4% on the quarter as investors reacted negatively to a clear deceleration in growth within key segments and margin pressures despite modest top-line gains, signaling discomfort with the company’s cautious outlook and uneven execution.

Key takeaways

Consolidated net sales increased 9% year-over-year, driven primarily by infrastructure hardware demand related to AI investment and supply chain agility.
Hardware grew 10%, led by networking, servers, and enterprise storage, each up more than 20%, while software revenue rose 11%; however, services revenue was flat, weighed down by warranty declines.
Commercial segment grew 10%, with broad-based demand, while government growth was modest at 5%, impacted by federal procurement delays and budget timing; education rose only 3%, with weakness in higher education offset by K-12 client device purchases.
Gross profit increased 6%, but non-GAAP operating income rose just 2%, reflecting margin compression from hardware mix shift and lower margin services, plus elevated discretionary expenses.
Despite record non-GAAP net income per share growth of 6% and strong cash flow generation, investors focused on deceleration trends and cautious commentary around near-term customer spending priorities and supply chain challenges.

Celanese Corporation

CE Q1 2026

Reported: 2026-05-07

The stock dropped 15.4% following the quarter as investors reacted negatively to a cautious outlook and signs of demand weakness across major end markets, undermining confidence in the company’s near-term growth prospects.

Key takeaways

Management acknowledged weak demand across key end markets, with only transient uplift from order pattern distortions (prebuys) in Q1.
The guidance for the second half assumes supply chain normalization and a moderate recovery in volumes and margins, reflecting continued uncertainty.
Despite operating some assets at high utilization (Clear Lake), supply chain challenges and cautious capacity ramp-ups highlight ongoing execution risks.
Engineered Materials segment shows resilience with pricing actions to offset feedstock inflation, but feedthrough delays persist.
Equity earnings from benzene-related operations are expected to remain flat versus last year, constrained by recent shutdowns and shipping disruptions.

Chegg, Inc.

CHGG Q1 2026

Reported: 2026-05-07

Chegg's Q1 2026 results beat expectations, driven by strong skilling revenue growth and robust free cash flow from Academic Services, fueling continued debt reduction and margin improvements. The market responded positively with a 3.2% stock gain on confidence in AI-driven growth and enterprise partnerships.

Key takeaways

Skilling revenue grew 9% to $17.6 million, with new enterprise distribution deals expected to accelerate growth in H2 2026.
Academic Services revenue reached $45.7 million, supported by solid retention despite ongoing traffic headwinds.
The company reduced costs by approximately 40% and is on track for zero debt, improving financial flexibility.
AI integration is enhancing personalized learning experiences and enabling faster curriculum updates, which management highlights as a competitive advantage.
Free cash flow exceeded expectations, underpinning investments in skilling and new AI-powered initiatives, including an AI master’s program launched via a partnership with Woolf.

Compass Diversified

CODI Q1 2026

Reported: 2026-05-07

Shares rose 3.4% post-earnings as Compass Diversified reported double-digit adjusted EBITDA growth in its Consumer segment and completed a strategic sale of Sterno’s food service business, highlighting operational strength amid macro uncertainty.

Key takeaways

Consumer subsidiaries drove strong performance, with double-digit adjusted EBITDA growth supported by nearly 25% revenue growth and over 40% EBITDA growth at The Honey Pot.
BOA posted 6.5% revenue growth and 11% EBITDA growth, benefiting from category-leading innovation and operational efficiency.
5.11 Tactical maintained solid margins and cash flow despite modest top-line pressure, with promising early results from a new retail concept.
Arnold nearly doubled adjusted EBITDA year-over-year despite supply chain headwinds due to export restrictions in China, reflecting strong demand for geopolitically secure rare earth magnets.
Strategic actions included the sale of Sterno’s food service business at an attractive valuation and use of sale leaseback proceeds at Altor for debt reduction, underscoring progress on deleveraging.

Core Scientific, Inc.

CORZ Q1 2026

Reported: 2026-05-07

Core Scientific’s stock rose modestly by 0.8% post-earnings, reflecting investor appreciation for continued execution and capital raises but tempered by no clear breakout in guidance or margins.

Key takeaways

Revenue-generating capacity reached approximately 245 megawatts, with an additional 200 megawatts expected shortly.
Closed a $3.3 billion capital raise tied to CoreWeave contracts to fund future growth and equipment purchases.
Five sites are fully leased and financed by tenants, underscoring capital efficiency but raising dependency on tenant-backed contracts.
Acceleration of development projects is underway at multiple sites, including a pivot at Pecos from Bitcoin mining to high-density colocation.
Management highlights increased customer engagement, especially among hyperscalers, chip makers, and AI labs, albeit noting that emerging customer segments require additional credit support.

Cirrus Logic, Inc.

CRUS Q4 2026

Reported: 2026-05-07

Cirrus Logic’s shares saw little change post-earnings (+0.3%), reflecting a quarter and fiscal year that largely met expectations without notable surprises. Revenue growth driven by smartphones and PCs was offset by cautious outlook commentary and limited incremental margin commentary, leading to a muted market response.

Key takeaways

Q4 revenue was $448.5 million, slightly above the midpoint of guidance, supporting full year revenue of $2 billion, up 5% year-over-year.
Record GAAP and non-GAAP earnings per share were reported for the full fiscal year, reflecting steady operational performance.
Core smartphone audio business showed sustained demand, benefiting from advanced products with extended lifecycles, though no acceleration was indicated.
High-performance mixed-signal (HPMS) products, including camera controllers and power management ICs, continued to expand, including new design wins in 3D sensing power solutions.
PC business contributed strong year-over-year revenue growth driven by multi-segment share gains and broader product portfolio adoption.

Curaleaf Holdings, Inc.

CURA.TO Q1 2026

Reported: 2026-05-07

Shares jumped 16.4% as Curaleaf delivered revenue growth that outpaced guidance and internal expectations, driven by strength in its international segment and supportive regulatory developments.

Key takeaways

Q1 revenue rose 6% year-over-year to $324 million, beating guidance and internal forecasts.
International segment revenue surged 35%, highlighting the growing importance of Curaleaf’s global platform.
Gross margin stood at 49%, with adjusted EBITDA of $63 million representing a 20% margin, despite a 170 basis point margin drag from international investments.
Net income from continuing operations was $70 million ($0.09 per share), a significant turnaround from last year’s loss of $50 million.
Regulatory progress, including medical cannabis rescheduling and potential 280E tax relief, underpinned investor enthusiasm and improved liquidity with a $500 million refinancing facility.

CVS Health Corporation

CVS Q1 2026

Reported: 2026-05-07

CVS Health's shares rose 8.2% following a better-than-expected quarter marked by an increased full-year adjusted EPS guidance and strong operational execution across segments.

Key takeaways

Reported adjusted operating income of $5.2 billion and adjusted EPS of $2.57 for Q1 2026.
Raised full-year adjusted EPS guidance to $7.30–$7.50, up from $7.00–$7.20.
Continued focus on lowering net costs via pharmacy benefits management, exemplified by $25 insulin pricing across 60,000+ pharmacies.
Accelerating biosimilar adoption by excluding branded STELARA from commercial formularies starting July 1, leveraging prior success with HUMIRA conversions.
Maintained industry leadership in prior authorization efficiency, with over 95% approvals within 24 hours and 88% of PA procedures standardized today.

DoorDash, Inc.

DASH Q1 2026

Reported: 2026-05-07

DoorDash’s stock rose 3.1% post-earnings, reflecting investor approval of solid engagement metrics and ongoing market share gains despite a cautious outlook on category expansion and product development timelines.

Key takeaways

DashPass membership engagement hit record levels, signaling strong customer retention and loyalty.
The company continues to gain market share across U.S. and international markets, supporting modest growth momentum.
Management emphasized ongoing investments in AI-driven product improvements to enhance customer experience, though concrete timing and impact remain uncertain.
Growth outside the core restaurant category remains nascent, with the addressable opportunity large but early in development.
Despite optimistic commentary, no clear guidance updates or margin expansion drivers were provided; the stock’s positive move mainly reflects confidence in the underlying customer metrics rather than near-term financial inflections.

Dave Inc. Class A Common Stock

DAVE Q1 2026

Reported: 2026-05-07

Shares dropped 5.5% after earnings as investors likely reacted negatively to signs of revenue and origination size deceleration, along with cautious outlook remarks despite management’s upbeat framing. The market evidently responded skeptically, focusing on deceleration and limited near-term impact from new initiatives despite strong headline growth figures.

Key takeaways

Revenue grew 47% year-over-year to $158.4 million, while adjusted EBITDA increased 57% to $69.3 million, maintaining a healthy 44% margin.
Member growth continues with 18% year-over-year increase in monthly transacting members, reaching 2.99 million, though still a small share of the total $185 million customer TAM.
Average ExtraCash origination size declined sequentially to $212 in Q1 from prior quarters, attributed to higher tax refunds, though it modestly rebounded to $214 in April.
Customer acquisition cost remained flat year-over-year at $18, improving sequentially by 11%, aiding member growth despite Q1 marketing challenges.
New Pay in 4 product, Dave Flex, launched in limited trial; management does not expect meaningful 2026 revenue contribution and emphasized a “test and learn” approach.

DuPont de Nemours, Inc.

DD Q1 2026

Reported: 2026-05-07

Shares popped 10.3% as DuPont delivered better-than-expected organic sales growth and margin expansion, prompting a full-year guidance raise and an accelerated share repurchase announcement.

Key takeaways

Reported 2% organic sales growth and 130 basis points of pro forma margin expansion in Q1.
Achieved double-digit adjusted EPS growth supported by disciplined commercial and operational execution.
Raised full-year 2026 financial guidance, citing strong first-quarter performance and price increases related to the Middle East conflict.
Announced a $275 million accelerated share repurchase under the existing program, signaling confidence in cash flow and capital allocation.
Continued operational improvements with better asset reliability, equipment effectiveness, and productivity initiatives underpinned by digital and AI tools.

DHT Holdings, Inc.

DHT Q1 2026

Reported: 2026-05-07

DHT Holdings shares edged down 0.5% following Q1 earnings, reflecting a largely in-line operational performance with no clear catalyst to drive significant upside or downside. The results showed steady revenue and strong liquidity, but the market appeared cautious amid spot rate volatility and future booking assumptions.

Key takeaways

Revenues on TCE basis totaled $157 million with adjusted EBITDA of $133 million; ordinary net income was $103.4 million or $0.64 per share after adjusting for non-recurring gains.
Fleet-wide average TCE daily rate was $78,800, with spot vessels earning $91,700/day and time charters at $61,300/day.
Fleet renewal continues with three newbuilds delivered and planned sale of three older vessels underway, including $51.5 million proceeds from one sale in Q1.
Strong liquidity maintained at $350 million, including $126 million cash and $230 million available under revolving credit facilities.
Q2 bookings include almost full coverage of time charter days at an average rate of $73,900/day plus spot days with an average of $168,300/day, though spot P&L breakeven is anticipated below zero.

Physicians Realty Trust

DOC Q1 2026

Reported: 2026-05-07

Shares rallied 19.1% following a standout quarter marked by an accretive IPO of the senior housing business, ongoing leasing momentum in outpatient medical properties, and an upgraded 2026 earnings outlook supported by strategic capital recycling and buybacks.

Key takeaways

Completed the Janus Living senior housing IPO, monetizing an 18% stake while maintaining exposure; current FFO from Janus portfolio valued at a ~20x multiple compared to Healthpeak’s.
Executed $700M+ acquisitions ahead of IPO to capture significant multiple arbitrage; IPO proceeds expected to add approximately $0.04 per share in earnings once fully invested and stabilized.
Outpatient Medical segment signed 1.1 million square feet of leases, achieving 5.4–5.8% cash re-leasing spreads, 79% tenant retention, and 91% total occupancy.
Raised $170 million via joint venture recapitalization with Blackstone at 6.1% cap rate, with plans for additional $700 million+ transactions at cap rates significantly above implied stock valuation.
Bought back $100 million of stock at >10% FFO yield, boosting 2026 guidance, while maintaining a 7.5% annualized dividend yield on a solid payout ratio.

Duke Energy Corporation

DUK Q1 2026

Reported: 2026-05-07

Duke Energy shares declined 1.5% following the quarter, reflecting investor caution despite steady progress; the market appears tempered by restrained near-term upside and margin headwinds not fully offset by ongoing strategic investments.

Key takeaways

Reported Q1 adjusted EPS of $1.93, consistent with management’s reaffirmed full-year guidance range of $6.55 to $6.80.
Capital investments continue aggressively, supported by the industry's largest regulated capital plan and regulatory approvals, including the Carolina utilities merger expected to drive $2.3 billion in customer savings through 2040.
Secured $5 billion+ in proceeds from asset monetizations (Brookfield minority stake in Florida utility, Piedmont Natural Gas sale) strengthening the balance sheet to support a $103 billion capital plan.
Executed 7.6 gigawatts in energy service agreements (ESAs), with nearly two-thirds under construction, positioning for long-term volume growth but reflecting near-term risks in execution and cost recovery.
Ongoing regulatory processes and recent rate stabilization filings highlight efforts to mitigate volatility; however, limited detail on margin trends or near-term earnings leverage likely restrains investor enthusiasm.

DaVita Inc.

DVA Q1 2026

Reported: 2026-05-07

DaVita's stock surged 25.8% as the company delivered better-than-expected volume growth, raised full-year guidance, and demonstrated early traction from technology investments supporting operational efficiency and clinical outcomes.

Key takeaways

Treatment volume came in slightly ahead of forecast, driven by better-than-expected mortality trends and patient transfers from Fresenius clinic closures.
Raised full-year volume growth expectations to 25-50 basis points, attributing about half the gain to Fresenius transfers and half to organic improvement.
Adjusted operating income of $482 million beat internal forecasts by approximately $50 million, with half due to actual performance and half due to timing benefits.
Adjusted EPS guidance was increased to a $14.10–$15.20 range, reflecting higher volume and lower patient care costs.
Continued investments in data infrastructure and AI, including deployment of ScheduleHub to optimize scheduling, are positioning the company for operational scale and improved clinical outcomes.

Devon Energy Corporation

DVN Q1 2026

Reported: 2026-05-07

Devon Energy’s shares dropped 11.1% following the earnings release, reflecting investor disappointment primarily due to a cautious outlook and the lack of clear guidance confirmation despite solid operational execution.

Key takeaways

Q1 production reached 387 thousand barrels per day, hitting the top end of guidance, signaling operational stability.
Capital spending came in 6% below the midpoint of guidance, aided by drilling and completion efficiencies from technology adoption.
Free cash flow totaled $816 million for the quarter, reflecting capital efficiency but overshadowed by investor concerns on forward visibility.
Management emphasized ongoing business optimization and AI-driven improvements but did not provide clear, upward guidance revisions for Q2.
The cautious tone around future growth and integration with Cotera Energy likely contributed to market skepticism despite current execution metrics.

Ellington Financial Inc.

EFC Q1 2026

Reported: 2026-05-07

Ellington Financial's shares rose 3.7% following a quarter highlighted by exceptional performance from its Longbridge segment, which delivered record net income and outpaced the prior year's full-year results despite seasonal headwinds. Strong origination volumes, improved securitizations, and solid credit metrics across the portfolio underpinned investor optimism.

Key takeaways

GAAP net income reached $0.78 per share with an annualized economic return of 26%.
Adjusted distributable earnings (ADE) of $0.55 per share comfortably exceeded the dividend of $0.39 per share.
Longbridge posted near-record proprietary reverse mortgage origination volumes and the lowest-ever cost of funds in its PropReverse securitization.
The company completed seven securitizations totaling $2.8 billion, more than double the volume from Q1 2025.
Delinquency rates declined for the second consecutive quarter, and realized credit losses remained minimal, supporting portfolio quality.

Emerson Electric Co.

EMR Q2 2026

Reported: 2026-05-07

Emerson’s 2Q results outpaced expectations, driven by strong demand in Software & Systems and robust margin expansion, supporting a 9.2% stock gain post-earnings.

Key takeaways

Underlying orders grew 5%, fueled by 18% Software & Systems growth and 41% growth in Ovation’s power segment orders.
Adjusted segment EBITDA margin expanded to 27.6%, surpassing expectations and reinforcing operational leverage.
Adjusted EPS of $1.54 landed near the top of guidance, enabling an upward revision of full-year EPS to $6.45–$6.55.
Annual contract value (ACV) for software increased 9% year-over-year to $1.64 billion, with continued strength anticipated into year-end.
Backlog rose 9% year-over-year to support second half confidence, despite a 1-point revenue headwind from the Middle East conflict.

EOG Resources, Inc.

EOG Q1 2026

Reported: 2026-05-07

Shares declined 7.1% after earnings as investors appeared disappointed by the cautious outlook and ongoing natural gas headwinds, which weighed on growth prospects despite solid operational execution.

Key takeaways

Generated $1.8 billion in adjusted net income and $1.5 billion in free cash flow in Q1 2026.
Returned nearly $950 million to shareholders via dividends and share repurchases during the quarter.
Production volumes, per-unit cash operating costs, and DD&A outperformed guidance midpoints.
Reallocated capital from natural gas to oil-focused assets due to near-term natural gas market softness and storage levels above the five-year average.
Highlighted geopolitical risks, especially the Iran conflict, as a key factor driving oil price volatility and market uncertainty.

Eaton Corporation plc

ETN Q1 2026

Reported: 2026-05-07

Eaton’s stock edged down 0.2% following its Q1 report, reflecting a largely in-line quarter with robust demand but no clear upside surprise to move the market materially.

Key takeaways

Reported record revenue of $7.5 billion and segment profit of $1.7 billion, with margins at 22.7%.
Rolling 12-month orders rose sharply: Electrical Americas up 42%, Electrical Global and Aerospace both up 13%.
Backlog hit record highs in Electrical and Aerospace, with combined book-to-bill at 1.2x on a rolling 12-month basis.
Elevated CapEx of over $1 billion underway to accelerate production ramp, notably in Americas.
Raised organic growth outlook by 200 basis points to a 10% midpoint and increased adjusted EPS midpoint to $13.28 for 2026, incorporating earnings dilution from Boyd Thermal acquisition.

Entravision Communications Corporation

EVC Q1 2026

Reported: 2026-05-07

Entravision’s stock surged 101.8% following a highly favorable market reaction driven by a substantial revenue gain and a return to operating profitability, particularly in the Advertising Technology & Services (ATS) segment which more than tripled revenue and quadrupled operating income year-over-year. The outsized stock move indicates investors are focused on the ATS segment’s outsized growth and profitability turnaround, overlooking the smaller Media segment headwinds and ongoing losses.

Key takeaways

Consolidated revenue jumped 114% to $197 million in 1Q ’26, reflecting strong growth primarily from the ATS segment.
ATS revenue increased dramatically from $51 million to $155 million, with operating income expanding from $7 million to $34 million.
Media segment revenue grew modestly by 4% to $42.4 million, driven by digital advertising and retransmission fees, but faced ongoing challenges with lower broadcast advertising and spectrum usage revenues.
Media segment operating loss widened to $5 million from $3 million due to increased expenses supporting sales capacity expansion and new programming initiatives.
Investment continued in ATS with increased engineering and sales capacity, driving rising infrastructure costs but also improved operating leverage.

Fresh Del Monte Produce Inc.

FDP Q1 2026

Reported: 2026-05-07

Fresh Del Monte Produce shares dropped 7.1% after earnings as investors reacted negatively to cautious outlook commentary and clear indications of margin pressure driven by rising input costs amid ongoing geopolitical disruptions.

Key takeaways

The newly completed Del Monte Foods acquisition contributed only one week of revenue, limiting immediate financial impact and visibility into integration benefits.
Management highlighted significant cost inflation pressures stemming from energy, fertilizers, packaging, and transportation, which are embedded in the supply chain and expected to weigh on margins through at least the second and third quarters.
The company anticipates margin compression, particularly in its fresh produce business, given its exposure to long production cycles and input intensity.
While the acquisition broadens Fresh Del Monte’s portfolio and store presence, near-term focus remains on stabilizing operations, managing costs, and evaluating synergies rather than expansion-driven growth.
The firm is initiating operational changes including asset optimization and cost management but flagged the challenging environment will remain a headwind in the near term.

Flex Ltd.

FLEX Q4 2026

Reported: 2026-05-07

Flex’s stock surged 37.9% following earnings, driven by investor enthusiasm around the announced spin-off of its Cloud and Power Infrastructure (CPI) segment and the strategic acquisition of Electrical Power Products (EP2), both signaling a sharpened growth focus and enhanced market positioning.

Key takeaways

The planned spin-off of the CPI segment into a standalone publicly traded company is expected to complete in Q1 2027, aiming to unlock value and sharpen strategic focus for both entities.
CPI (SpinCo) is positioned as a leader in power, thermal, and compute integration tailored for AI data centers and mission-critical infrastructure, addressing a clear market need for unified power and thermal solutions.
Flex’s core business post-spin will concentrate on advanced manufacturing across health care, robotics, warehouse automation, and networking—higher-growth end markets with potential for margin expansion.
Recent acquisition of EP2 enhances Flex’s electrical power capabilities and strengthens its exposure to utility-grade, margin-accretive grid modernization projects, complementing data center growth.
The company has secured significant incremental orders from hyperscalers, including Google, underscoring ongoing demand momentum despite industry challenges.

Flutter Entertainment plc

FLUT Q1 2026

Reported: 2026-05-07

Flutter shares fell 2.1% after earnings, reflecting investor caution around the ongoing challenges in the sportsbook segment, including a smaller player base entering 2026 due to high gross revenue margins last quarter and only modest underlying growth despite various promotional efforts.

Key takeaways

U.S. sportsbook AMPs declined 1% year-over-year, with revenue up 6%, but performance remains impacted by persistent margin pressure and fewer active players.
Management outlined plans to improve generosity and product offerings, including a loyalty program rollout and new features like Bet Protect+, which has seen encouraging adoption.
FanDuel iGaming showed a healthy 10% AMP growth and 19% revenue growth, driven by casino player expansion and enhanced rewards.
Prediction markets remain a nascent area with modest revenues in Q1 but are viewed as an incremental growth avenue; the FanDuel One App launch aims to unify customer experience.
Internationally, Italy led growth with strong online performance, though the Snai business still faces integration headwinds pending the SEA platform migration completion in April.

Freshworks Inc. Class A Common Stock

FRSH Q1 2026

Reported: 2026-05-07

Shares declined modestly by 1% following Freshworks' Q1 report, reflecting investor caution despite stable growth, with no clear upside catalyst strong enough to drive the stock higher amid ongoing margin pressures and a restrained outlook.

Key takeaways

Q1 revenue rose 16% year-over-year, slightly above internal targets, with EX ARR growing 27% driven by mid-market and enterprise customer expansion.
Non-GAAP operating margin was 18%, approximately 3 points above estimates, while adjusted free cash flow margin reached 24%, indicating solid profitability metrics.
AI product adoption showed strong momentum: Freddy AI Copilot customer growth exceeded 80% YoY, with over 1/3 of new EX customers attaching Copilot.
CX ARR growth remained modest at 6% YoY, highlighting slower progress compared to EX business and ongoing replatforming efforts.
Despite notable enterprise deals and AI integration advances, investor response suggests concerns over deceleration in CX growth and limited incremental visibility into FY26 guidance.

Flotek Industries, Inc.

FTK Q1 2026

Reported: 2026-05-07

Flotek’s stock fell 3.9% following a cautious outlook that tempered enthusiasm despite strong data analytics growth; investors appear concerned about margin pressures and the reliance on a nascent segment amid a challenging market environment.

Key takeaways

Total company revenue grew 27% year-over-year, driven by a 295% surge in data analytics revenue.
Data analytics now contributes 50% of gross profit, up sharply from 8% in the prior year, but the segment is still evolving.
Industry technologies revenue increased 13%, despite historically low completions activity in North America.
Adjusted EBITDA improved 44% year-over-year, reflecting overall operational leverage.
Management highlighted a multiyear transformational shift toward a data-as-a-service business model, but investors likely reacted negatively to cautious forward commentary and margin headwinds implied in the segment mix transition.

Fortinet, Inc.

FTNT Q1 2026

Reported: 2026-05-07

Fortinet’s stock rallied 20.1% post-earnings, driven by billings growth well above expectations and a confident raised outlook, reflecting strong demand across its secure networking and AI-driven solutions.

Key takeaways

Total billings surged 31% to $2.09 billion, led by 32% growth in secure networking and over 70% growth in operational technology (OT) security billings.
Product revenue jumped 41% to $645 million, fueled by AI-related deployments and customer upgrades to higher-performance FortiGate hardware.
Unified SASE billings grew 31%, with FortiSASE adoption expanding significantly within large enterprise accounts (18% penetration, +45% increase).
Service revenue increased 11% to $1.21 billion, aided by accelerating service billings growth of 27% and deferred revenue up 15%.
Operating margins remained strong, with GAAP margin at 31% and non-GAAP at 36%, supporting a 29% increase in GAAP EPS and $1 billion in free cash flow.

fuboTV Inc.

FUBO Q2 2026

Reported: 2026-05-07

Fubo’s shares dropped 13% post-earnings, reflecting investor disappointment primarily driven by cautious outlook and signs of deceleration despite record revenue and adjusted EBITDA milestones.

Key takeaways

Reported record revenue for Q2 2026, supported by the expanded Fubo and Hulu + Live TV offerings.
Achieved over $100 million in trailing 12-month pro forma adjusted EBITDA, nearing the long-term target.
Integration initiatives with ESPN and AI-driven features announced, aiming to enhance customer engagement and expand distribution.
Margins and growth guidance remained cautious, failing to fully reassure investors given the broader market context.
Minimal incremental churn post loss of NBCU content, but this did not offset concerns about overall growth momentum.

The GEO Group, Inc.

GEO Q1 2026

Reported: 2026-05-07

The GEO Group's shares rallied 15.6% following an earnings report that highlighted significant contract-driven revenue growth and a robust outlook supported by new and expanded ICE-related services.

Key takeaways

Incremental annual revenues from new or expanded contracts in 2025 total approximately $520 million, the highest in company history.
ICE Secure Services segment revenue boosted by activation of four facilities with approximately 6,000 beds and reactivation of Adelanto Processing Center; total ICE beds under contract now about 26,000.
ISAP 5 contract continued stable participant counts (~180,000), with a shift toward higher-priced GPS ankle monitors increasing revenue potential.
New transportation contracts with ICE and U.S. Marshals valued at around $60 million in incremental annual revenue.
Guidance for 2026 raised to reflect strong first quarter performance, with several unrecognized upside opportunities cited.

GlobalFoundries Inc. Ordinary Shares

GFS Q1 2026

Reported: 2026-05-07

GlobalFoundries delivered a quarter that impressed the market, with shares rising 6.7% after earnings driven by strong demand and margin-accretive growth in silicon germanium (SiGe) solutions and positive momentum in optical networking. The market responded favorably to evidence of accelerating revenue quality and capacity expansion in high-growth end markets.

Key takeaways

SiGe capacity at the Vermont fab is oversubscribed well into 2027, reflecting robust customer demand and prompting capacity expansion plans.
Double-digit percentage growth was reported in automotive, communications infrastructure, and data center segments, signaling solid secular end-market traction.
Optical networking leadership was underscored by multiple technology launches, including a complete OCI MSA-capable silicon photonics platform exceeding industry standards.
Non-IFRS profitability metrics met or exceeded the high end of guidance ranges, indicating disciplined cost management and operational execution.
The company is focused on enhancing revenue composition and scaling its global manufacturing footprint, with further strategic details expected at Investor Day.

Barrick Gold Corporation

GOLD Q3 2026

Reported: 2026-05-07

Shares rose modestly by 1.3% following fiscal Q3 results that showed robust revenue and profit gains largely driven by acquisitions and favorable market conditions. However, the muted market reaction suggests investors remain cautious amid rising expenses and a return to more normalized activity levels.

Key takeaways

Q3 revenue surged 244% year-over-year to $10.3 billion, fueled by higher metal prices, volume growth, and the addition of recent acquisitions including Monex.
Gross profit increased 331% to $176 million, improving margin slightly to 1.7% from 1.36%, supported by strong performance across Wholesale, Ancillary Services, and Direct-to-Consumer segments.
SG&A expenses rose 134% to $78 million, driven by increased compensation accruals (+$27M), advertising (+$7M), insurance (+$4M), and other operational costs; expenses from acquisitions also added $33 million.
Market activity moderated late in the quarter after a period of extreme volatility, leading to a more normalized trading environment going forward.
Strategic equity investment from Tether and new partnerships with their affiliates reinforce capital position but add complexity amid evolving digital asset integration.

Gladstone Commercial Corporation

GOOD Q1 2026

Reported: 2026-05-07

Shares declined 1.2% following the quarter as cautious outlook nuances and margin pressures offset steady operational metrics, suggesting investors remain wary despite stable fundamentals.

Key takeaways

FFO and core FFO per share rose modestly to $0.35 from $0.34 year-over-year, reflecting limited earnings growth.
Same-store lease revenue increased by 1%, driven by higher recovery fees and rental rate bumps from leasing activity.
Operating revenues grew to $41.9 million from $37.5 million year-over-year, primarily due to portfolio expansion and improved recovery revenues.
Operating expenses increased to $25.2 million from $23.9 million, with higher depreciation from portfolio growth offset only partially by incentive fee credits.
Portfolio occupancy remained strong at 98.7% with a 7.3-year average lease term, though the company continues to evaluate office holdings and focus on strategic industrial asset growth.

Granite Point Mortgage Trust Inc.

GPMT Q1 2026

Reported: 2026-05-07

Shares of Granite Point Mortgage Trust rose 9.2% following the quarter as investors responded positively to active loan repayments, asset sales above par, and continued portfolio de-risking that set a clearer path for future growth.

Key takeaways

Total loan portfolio commitments stood at $1.6 billion with $1.5 billion in outstanding principal, diversified across 40 investments and a weighted average LTV of 66% at origination.
The portfolio’s weighted average risk rating rose to 3.2 from 2.9, reflecting some asset downgrades, including a $15 million hotel loan moved to risk rating five due to credit concerns.
The quarter featured $189 million in repayments, paydowns, sales, and amortization; notably, two full loan repayments totaled $174 million, and a $13 million B note sale on a hotel closed above par.
Post-quarter, the company resolved a $76 million Chicago retail loan on nonaccrual with an expected $30.2 million write-off covered by reserves, reducing risk-rated five loans to four with $189 million principal remaining.
Management emphasized capital recycling through sales, partial repayments, and limited new originations aiming to optimize the balance sheet and rebuild the portfolio as market conditions improve.

Global Payments Inc.

GPN Q1 2026

Reported: 2026-05-07

Global Payments delivered a broadly in-line quarter, with a modest 1.0% stock gain reflecting neither clear upside nor downside surprises. While the Worldpay integration shows promising early momentum, the market appears cautious on the overall near-term growth and profitability trajectory.

Key takeaways

Adjusted net revenue grew approximately 5.5% (4.5% on a constant currency basis), supported by underlying consumer spending but partially offset by lower volumes in the Middle East and IRS payment impacts from tax reforms.
Adjusted operating margins expanded by 110 basis points, demonstrating disciplined cost management amid integration efforts.
Adjusted EPS increased 10% on both reported and constant currency bases, reflecting consistent operating model execution.
More than $600 million returned to shareholders in Q1 through dividends and buybacks; an additional $500 million accelerated share repurchase announced.
Early Worldpay integration is advancing well: sales synergies with Genius platform noted, including new partner wins and increased cross-sell opportunities; SMB e-commerce sales up 25% sequentially and over 100% YoY.

Grab Holdings Limited Class A Ordinary Shares

GRAB Q1 2026

Reported: 2026-05-07

Grab's shares were largely unchanged after the earnings release, reflecting a market assessment that the company delivered growth in key metrics but did not materially alter the outlook or surprise investors in either direction.

Key takeaways

On-demand GMV grew 24% year-over-year in Q1, indicating continued activity expansion despite seasonal softness.
Monthly transacting users (MTUs) reached 52 million, highlighting steady user engagement across Southeast Asia.
Financial Services loan disbursals surged 67%, surpassing $1 billion in the quarter and on track for segment adjusted EBITDA breakeven in H2 2026.
The company achieved its 17th consecutive quarter of adjusted EBITDA growth, with trailing 12-month adjusted free cash flow expanding to $489 million.
Management reiterated full-year guidance for revenue between $4.04 billion and $4.10 billion, and adjusted EBITDA of $700 million to $720 million despite ongoing macro risks like fuel price volatility.

HCI Group, Inc.

HCI Q1 2026

Reported: 2026-05-07

HCI Group’s shares declined 1.3% after reporting a quarter characterized by steady earnings growth and stable underwriting metrics, but the market reaction suggests investors were unimpressed by the lack of clear upside or notable positive catalysts. The absence of a marked positive catalyst appears to have limited the stock’s upside despite a solid operational quarter.

Key takeaways

Pretax income increased 15% year-over-year to $115 million; diluted EPS was $5.45.
Gross premiums earned rose just over 8%, with total revenue up slightly more than 12%, supported by increased investment and other income.
Loss ratio held steady at 20%, consistent with last year’s quarter, while combined ratio remained at 57%, indicating ongoing underwriting discipline.
Balance sheet strengthened with stockholder equity doubling to over $1 billion and debt-to-capital ratio at a low 6%.
Share repurchase program is active, with $37.5 million used to buy back 239,000 shares since authorization in March.

HelloFresh SE

HFG.DE Q1 2026

Reported: 2026-05-07

Shares declined 1.4% as investors weighed continued revenue deceleration and margin pressures despite progress in operational improvements and strategic investments, signaling cautious sentiment on near-term growth prospects.

Key takeaways

Group revenue declined 7.7% in constant currency, marking a continued top-line shrinkage despite sequential improvement in meal-kit revenue decline to 8.5%.
Adjusted EBITDA was EUR 24 million, materially impacted by EUR 25 million of severe weather disruptions; excluding this, underlying EBITDA stood near EUR 49 million.
Operational efficiency gains were evident with fulfillment costs improving 0.8 percentage points year-over-year and marketing spend reduced by EUR 62 million, equating to 21.8% of revenue.
Investments in product quality substantially improved average order value (+EUR 4.2 group-wide, +4.5% in meal kits) and customer retention metrics, though not yet sufficient to offset the revenue contraction and associated deleveraging.
Ready-to-eat segment losses narrowed 40% year-over-year, supported by operational fixes and marketing discipline, but active customer base remains below prior levels, delaying growth recovery.

Horizon Technology Finance Corp

HRZN Q1 2026

Reported: 2026-05-07

Horizon Technology Finance’s +6.6% stock reaction reflects investor approval of its growing portfolio and strong yield performance, driven by successful deployment of merger capital and an expanding committed backlog.

Key takeaways

Portfolio grew for a second consecutive quarter to nearly $700 million, with $120 million funded across five new investments.
Generated net investment income (NII) of $0.19 per share, exceeding monthly distributions totaling $0.09 per share (regular plus special).
Quarterly portfolio yield on debt investments remained elevated at 15.2%, consistent with industry-leading levels.
Committed and approved backlog increased to $180 million, up $26 million from Q4 2025, supporting near-term portfolio growth.
Announced a $10 million stock repurchase program to capitalize on dislocation between share price and net asset value.

HealthStream, Inc.

HSTM Q1 2026

Reported: 2026-05-07

HealthStream’s shares rose 8.9% post-earnings, driven by better-than-expected revenue growth and margin expansion, supported by strong demand in its healthcare workforce platforms and renewed confidence in AI-driven initiatives.

Key takeaways

Quarterly revenues reached $81.2 million, up 10.5% year-over-year.
Adjusted EBITDA rose 24.1% to $20.1 million, reflecting margin improvement.
Operating income increased significantly by 71% year-over-year, signaling strong operational leverage.
Management reaffirmed full-year 2026 guidance, with revenues expected between $323 million and $330 million.
Continued focus on investing in AI and product innovation, leveraging the scalable hStream platform and unique data assets.

Hut 8 Corp.

HUT Q1 2026

Reported: 2026-05-07

The stock surged 25.7% following the quarter, driven by the announcement of a landmark long-term AI data center deal that significantly exceeds typical contract values, underscoring investor enthusiasm for Hut 8’s differentiated power-first infrastructure strategy and durable, investment-grade revenue streams.

Key takeaways

Signed a 15-year, triple net lease for the first phase of the 1 gigawatt Beacon Point AI data center campus with 352 megawatts IT capacity (500 megawatts utility capacity).
The base term contract value is $9.8 billion, including a 3% annual escalator; potential contract value exceeds $25 billion with renewal options.
Deal anchored by a high investment-grade counterparty, reflecting durable and predictable cash flows.
The site was underwritten on a “power-first” basis with built-in flexibility, supported by diverse demand including the spin-off American Bitcoin business as an initial anchor.
The company’s restructured balance sheet and nonrecourse asset-level debt enable unique financial optionality to fund growth opportunistically.

IAMGOLD Corporation

IAG Q1 2026

Reported: 2026-05-07

The market responded positively with a 12.4% stock gain, driven by cash flow generation and balance sheet improvements that support aggressive shareholder returns and ongoing growth catalysts.

Key takeaways

Produced 183,600 attributable ounces of gold in Q1, starting the year on track for full-year guidance of 720,000 to 820,000 ounces.
Generated $525 million mine-site free cash flow, enabling the repayment of $100 million in debt and a $260 million share buyback during the quarter.
Increased cash position by $128 million, further strengthening the balance sheet.
Cash costs including royalties stood at $1,608 per ounce with all-in sustaining costs at $2,124 per ounce, affected by elevated gold price-related royalties and rising energy costs.
Upcoming catalysts include updated technical reports across key assets and potential mine life extensions, supporting long-term production growth and shareholder value creation.

IBEX Limited

IBEX Q3 2026

Reported: 2026-05-07

The stock rose 15.6% as ibex reported sustained double-digit revenue growth driven by strong client retention, accelerating growth in the health tech vertical, and the promising strategic partnership integrating AI technology, signaling optimism about its differentiated positioning in a shifting BPO landscape.

Key takeaways

Revenue grew 17% year-over-year to $164.4 million, marking five consecutive quarters of double-digit growth.
Adjusted EPS increased 11% to $0.91, with eight straight quarters of double-digit EPS growth.
Top 10 client revenues grew over 25% on average in the past five quarters, supported by 100% client retention this quarter and 99.9% annual revenue retention.
Health tech vertical expanded nearly 54%, set to surpass $100 million this fiscal year, demonstrating successful new vertical scaling.
Announced a strategic partnership with Sierra AI to integrate advanced AI solutions with human-powered CX, driving early wins and positioning ibex as a leader in BPO 3.0.

Icahn Enterprises L.P.

IEP Q1 2026

Reported: 2026-05-07

Icahn Enterprises’ stock fell 4.2% post-earnings as investors reacted negatively to significant losses in refining hedges and derivative positions, which weighed heavily on overall profitability despite some segment gains.

Key takeaways

Reported a net loss attributable to Icahn Enterprises L.P. of $459 million, or $0.71 loss per unit, reflecting substantial hedging and derivative losses.
The Investment segment suffered $425 million in losses on refining hedges, turning a 4.4% quarterly gain (excluding hedges) into an overall negative 8.2% return.
Net short notional exposure in the funds increased sharply to 29% at quarter-end from 13% at year-end, indicating a more defensive stance amid volatility.
Energy segment posted a small adjusted EBITDA loss of $5 million, marginally better than the prior year, with refining utilization strong at 97% but margins pressured by higher Renewable Fuel Standard (RFS) costs and unrealized losses.
Automotive Services revenue declined by $9 million due to store closures, partially offset by price increases, highlighting headwinds in this segment.

International Flavors & Fragrances Inc.

IFF Q1 2026

Reported: 2026-05-07

IFF’s shares rose 10.6% following the first quarter, driven by better-than-expected volume growth across all segments, strong margin expansion, and improved cash flow despite ongoing global uncertainties.

Key takeaways

Revenue grew 3% to over $2.7 billion, supported by mid-single-digit volume growth in Health & Biosciences and low single-digit increases across Taste, Food Ingredients, and Scent.
Adjusted EBITDA rose 8% to $568 million, with EBITDA margin expanding 110 basis points to 20.7%, the highest since Q2 2022, fueled by productivity improvements and favorable pricing.
Taste segment sales increased 2% with an 18% EBITDA gain, led by volume and pricing strength, particularly in Greater Asia.
Food Ingredients posted 3% sales growth and a 12% EBITDA increase, driven by strong volume (5%) and productivity; volume growth was the highest in several years.
Health & Biosciences delivered 5% volume-driven sales growth across most businesses and 7% EBITDA growth, reflecting robust demand in Animal Nutrition and Food Biosciences.

Infineon Technologies AG

IFX.DE Q2 2026

Reported: 2026-05-07

Shares declined 1.7% following Q2 results as investors digested margin pressure from the automotive segment’s high-voltage semiconductor business and a cautious near-term outlook despite broadly stable revenue.

Key takeaways

Revenue rose 4% sequentially and 6% year-over-year to €3.812 billion, supported by improving demand across several end markets.
Segment earnings margin decreased to 17.1% from 17.9%, primarily due to price adjustments and costs related to restructuring the automotive high-voltage power semiconductor business.
Automotive revenue edged up to €1.83 billion with earnings margin compressing sharply to 18.1% from 22.1%, driven by intensified competition and declining prices in the high-voltage powertrain segment.
Order backlog increased significantly by €4 billion quarter-on-quarter to around €25 billion, reflecting strong order intake and rising demand in AI and industrial applications.
Free cash flow remained negative at -€63 million but improved from the previous quarter’s -€199 million, reflecting ongoing investment and restructuring costs.

International General Insurance Holdings Ltd.

IGIC Q1 2026

Reported: 2026-05-07

The 3.0% stock gain reflects modest investor approval of IGI’s disciplined underwriting amid challenging conditions, with resilience shown in improved underwriting income and combined ratio despite geopolitical headwinds and a decline in premiums.

Key takeaways

Gross written premiums declined 4.5% year-over-year to $197.2 million, influenced by cycle management and the nonrenewal of two reinsurance programs.
Underwriting income rose 35.1% to $37.7 million, driving an improved combined ratio of 89.1%, down 5.3 points from Q1 2025 and in line with long-term averages.
The combined ratio included about $15 million of net losses related to the Middle East conflict, alongside 29 points of favorable prior year reserve development.
Return on average equity stood at 12.7%, with core ROE at 14.3%, consistent with historical performance.
Book value per share slightly declined to $15.60 after nearly $65 million was returned to shareholders through dividends and share repurchases.

InMode Ltd.

INMD Q1 2026

Reported: 2026-05-07

Shares dropped 3.3% following earnings as investors reacted to margin compression and cautious outlook reflected in weaker profitability metrics despite modest revenue growth.

Key takeaways

Revenue rose 5% year-over-year to $82 million, driven primarily by the U.S. market; international sales grew 2.65% to $38.7 million.
Gross margin declined significantly, with GAAP gross margin falling to 75% from 78% a year ago and non-GAAP gross margin down to 75% from 79%.
Operating expenses increased sharply, with GAAP operating expenses up 13.7%, largely due to restructuring of North American sales and expansion efforts.
Operating margins compressed notably, as GAAP operating margin dropped to 12% from prior levels, and non-GAAP operating margin declined to 17% from 23%.
Earnings per share declined: GAAP EPS fell to $0.18 from $0.26, and non-GAAP EPS decreased to $0.25 from $0.31, underscoring margin pressure and cautious execution.

Intapp Inc. Common Stock

INTA Q3 2026

Reported: 2026-05-07

Intapp’s shares edged down 0.4% post-earnings as the market took a neutral stance, reflecting solid top-line growth but hesitance around visibility into sustained momentum beyond product innovation and adoption signals.

Key takeaways

Cloud ARR rose 31% YoY to $459 million, now constituting 82% of total ARR of $560 million.
SaaS revenue increased 27% YoY to nearly $108 million; total revenue advanced 13% YoY to $146 million.
Management highlighted strong client engagement initiatives, including a 40% increase in Amplify event attendance and significant digital engagement gains.
The company positioned its new AI platform, Celeste, as a strategic differentiator aimed at expanding addressable market and consumption-based revenue.
Despite enthusiasm around AI integration and strategic partnerships, the market reaction suggests investors remain cautious on near-term performance and execution risks.

IonQ Inc. Common Stock

IONQ Q1 2026

Reported: 2026-05-07

IonQ’s shares declined 0.7% following earnings, reflecting investor caution despite record revenue growth, as the market appears to discount potential margin pressure and an absence of incremental upside in guidance.

Key takeaways

Reported Q1 2026 GAAP revenue reached $64.7 million, more than 8 times the year-ago period, marking the largest quarter in company history.
Raised full-year revenue guidance to a high-end target of $270 million, reflecting confidence in sales scale and cloud utilization.
Highlighted commercial progress with pre-sales of the first 256-qubit chip-based system, targeting customer commissioning by mid-2027.
Emphasized long-term technology leadership through a detailed fault-tolerant quantum computing blueprint, positioning IonQ ahead in scalable system development.
The modest stock decline implies investors may be weighing margin sustainability and possibly tempered near-term growth expectations despite technological milestones.

Inter Parfums, Inc.

IPAR Q1 2026

Reported: 2026-05-07

Shares of Inter Parfums rose modestly by 2.5% following the quarter, reflecting steady sales growth tempered by ongoing regional challenges and mixed brand performance.

Key takeaways

Consolidated sales increased 2% on a reported basis, supported by growth in North America (+7%) and Central/South America (+23%).
Coach led brand performance with a 30% sales increase, fueled by new product extensions and sustained demand.
Challenging markets weighed on results, including a 12% sales decline in Eastern Europe and Middle East/Africa, and a 7% decrease in Asia Pacific due to distribution changes and softer demand.
Lacoste sales fell 12%, reflecting prior-year comparables and ongoing regional headwinds.
The company is expanding its portfolio with new brands and long-term licensing deals, targeting premium and lifestyle fragrance segments in the coming years.

IPG Photonics Corporation

IPGP Q1 2026

Reported: 2026-05-07

IPG Photonics shares plunged 16.7% after the quarter as investor confidence was hit by deceleration in Advanced Solutions revenue and cautious near-term outlook signals, despite solid Industrial Solutions growth. The miss in growth drivers and sequential weakness in non-industrial segments clearly disappointed the market.

Key takeaways

Total revenue increased 17% year-over-year, driven by Industrial Solutions, which grew 21% and represented 86% of total sales.
Industrial Solutions revenue was sequentially flat, underperforming typical seasonal trends despite strong growth in welding and cutting tied to battery manufacturing.
Advanced Solutions, contributing 14% of sales, declined modestly year-over-year and saw sequential revenue declines due to weaker medical sales and cyclical softness in micromachining.
Book-to-bill ratio remained above 1 for a second consecutive quarter, signaling solid order intake but not enough to offset concerns on margin and segment growth trajectory.
Defense segment showed promise with continued interest and a $10 million follow-on order from Lockheed Martin for its Crossbow laser system, but broader Advanced Solutions softness weighed on sentiment.

ITT Inc.

ITT Q1 2026

Reported: 2026-05-07

The stock declined 2.3% following earnings, reflecting investor caution despite solid top-line growth and margin expansion; concerns likely center on the cautious outlook embodied in modest organic growth guidance and integration execution risks, rather than any outright earnings or revenue disappointment.

Key takeaways

Reported revenue rose 33% (11% organically), driven by all segments with Flow Technologies leading at 61% growth (12% organic), reflecting strong acquisition synergies.
Orders increased 26% (8% organically) with broad-based strength, including double-digit gains in aerospace, industrial connectors, and friction products.
Operating margins expanded by 130 basis points to 21.1%, supported by volume growth and productivity gains offsetting price pressure; Flow Technologies improved margin by 100 basis points to 23.7%.
Adjusted EPS increased 25%, though guidance for full-year organic revenue growth of 5% and adjusted EPS range of $7.70–$8.00 (9% growth midpoint) signals a more cautious outlook.
Integration of SPX FLOW is progressing, with $80 million synergies targeted and early execution on cost reductions, but ongoing integration risks may weigh on sentiment.

Jacobs Engineering Group Inc.

J Q2 2026

Reported: 2026-05-07

Jacobs shares fell 3.2% post-earnings as investors focused on margin compression pressures despite solid revenue growth and backlog expansion, signaling concerns over profitability sustainability amid the PA Consulting acquisition.

Key takeaways

Adjusted EPS grew 22% to $1.75, supported by 9% organic net revenue growth and 70 basis points of year-over-year margin expansion.
Backlog increased 22% to a record $27 billion, with a trailing 12-month book-to-bill ratio of 1.4x on gross revenue and 1.2x on net revenue.
Gross revenue grew 27% year-over-year; adjusted EBITDA rose 14% to $327 million, but margins compressed to 14.1%.
Strong growth in life sciences and advanced manufacturing (+12% net revenue growth) and critical infrastructure (+9% net revenue growth), led by double-digit growth in transportation.
The acquisition of PA Consulting caused a wider than usual GAAP to adjusted EPS spread, indicating temporary earnings quality challenges and contributing to investor caution.

Joby Aviation Inc. Common Stock

JOBY Q1 2026

Reported: 2026-05-07

The stock rallied 15.3% following the quarter as investors responded positively to Joby Aviation’s clear progress on regulatory engagements, infrastructure partnerships, and scaled production efficiencies, signaling advancing maturity and execution momentum well ahead of FAA certification.

Key takeaways

Joby secured participation in the White House-backed eVTOL Integration Pilot Program (eIPP) across 11 states, enabling accelerated market entry before FAA certification.
Demonstrated operational capabilities with FAA conforming aircraft flights in complex airspaces, including inaugural eVTOL flights linking JFK and Manhattan heliports.
Infrastructure developments advanced globally, highlighted by partnerships for vertiports in New York, LA, San Jose, and a commercial vertiport in Dubai, reflecting expanding customer access points.
Production scale-up continues with a 2.5x increase in composite parts output year-over-year and introduction of a third shift, indicating strengthening manufacturing capacity and quality improvements.
Toyota’s production system principles are being integrated to optimize factory-floor efficiency and collaboration, supporting sustainable ramp-up ahead.

Jackson Financial Inc.

JXN Q1 2026

Reported: 2026-05-07

Jackson Financial’s shares edged up 1.5% following their Q1 report, reflecting investor caution despite solid underlying performance and stable capital generation. The market appears to be digesting the earnings as largely in line with expectations without a clear catalyst for a stronger move.

Key takeaways

Adjusted capital totaled $5.5 billion, up nearly 5% year-over-year, supporting consistent capital returns and shareholder distributions.
Pretax operating earnings increased 12% year-over-year on an adjusted basis, with an 18% earnings-per-share gain aided by share repurchases.
Retail annuity sales grew 31%, driven by strong demand for RILA products, which have now exceeded $2 billion in quarterly sales since launch in May 2025.
Fixed annuity and FIA sales reached $750 million, a significant jump from $174 million a year ago, reflecting initial success of the FIA launched in August 2025.
Net outflows improved by 30% year-over-year and declined modestly from the prior quarter, though variable annuity withdrawals are expected to continue as the block matures.

The Kraft Heinz Company

KHC Q1 2026

Reported: 2026-05-07

Shares rose 5.0% following Q1 results, driven by better-than-expected market share gains and positive category repositioning despite ongoing headwinds from inflation and anticipated Q2 topline decline due to seasonal timing and SNAP-related pressures.

Key takeaways

Q1 saw market share improvements, with 58% of categories gaining or holding share in March versus only 21% a year ago.
The company reclassified product platforms, downgrading Frozen from "Win Big" to "Hold" but upgrading Hydration to "Win Big" and Cheese to "Win," reflecting shifting portfolio priorities.
Guidance remains unchanged, forecasting Q2 sales declines of 3-5% due to Easter timing and a 100bps SNAP headwind; management notes market softness.
Inflation pressures are intensifying, especially on resins and energy costs, with hedges in place through Q3 but risks remain if volatility persists.
Management points to underlying operational improvements and disciplined resource deployment, with $600 million in incremental investments planned for the year.

Kemper Corporation

KMPR Q1 2026

Reported: 2026-05-07

Kemper shares fell 10.6% following a disappointing quarter marked by elevated loss costs in California’s personal auto segment and statutory premium refunds in Florida. These pressures drove margin compression and earnings shortfalls, outweighing solid performance in commercial auto and life insurance.

Key takeaways

California personal auto results were significantly pressured by increased minimum liability limits, leading to higher loss costs and attorney involvement in claims.
Florida results were negatively impacted by mandatory statutory premium refunds due to regulatory profit thresholds, despite ongoing profitable growth in the current auto business.
Commercial auto posted its best production quarter ever, representing a bright spot amid overall headwinds.
Life insurance operations continued to deliver steady, diversified earnings contributions.
Management is executing restructuring initiatives targeting over $60 million in annual run-rate savings and claims process improvements to address ongoing cost challenges.

Kratos Defense & Security Solutions, Inc.

KTOS Q1 2026

Reported: 2026-05-07

Shares of Kratos Defense fell 3.9% following the earnings release, reflecting investor disappointment likely tied to cautious outlook signals and margin concerns despite solid order growth and backlog expansion.

Key takeaways

Book-to-bill ratio improved to 1.6:1 overall, with satellite business posting an impressive 3:1 ratio in Q1.
Record backlog reached $2 billion, with a pipeline expanding to $14 billion, signaling strong future demand.
EBITDA margins expected to increase by 100 basis points year-over-year in both 2026 and 2027, driven by production leverage and higher-margin product mix.
Management emphasized substantial Department of War funding increases and multiyear agreements but provided limited detail on near-term revenue visibility or specific margin trends.
Despite optimistic long-term outlook and investments, lack of explicit guidance clarity or updated financial forecast points to investor caution.

Klaviyo, Inc.

KVYO Q1 2026

Reported: 2026-05-07

Klaviyo’s stock dropped 32.4% after the quarter as investors reacted to signs of notable deceleration and cautious outlook concerns, particularly in growth momentum despite solid revenue gains and margin expansion.

Key takeaways

Revenue grew 28% year-over-year to $358 million, reflecting continued top-line expansion.
Non-GAAP operating margin improved to over 16%, the highest in the company’s history, indicating ongoing margin discipline.
Customer count surpassed 196,000 brands, with a record number of multimillion-dollar ARR deals closed.
Largest customers’ revenue (GMV) grew roughly 2x faster than the broader market, highlighting strength with marquee clients.
Despite these positives, management’s remarks and the steep stock decline suggest investors are concerned about slowing growth dynamics and a cautious outlook not fully offset by margin gains or product innovation.

Centrus Energy Corp.

LEU Q1 2026

Reported: 2026-05-07

Centrus Energy’s Q1 results prompted little market reaction, with the stock unchanged at +0.1%, reflecting a quarter of moderate revenue and backlog progress but limited operating income expansion and an uncertain near-term outlook in government procurement.

Key takeaways

Revenue reached $76.7 million with gross profit at $31.5 million, but operating income was minimal at $0.8 million.
Adjusted net income was $23.5 million, translating to adjusted diluted EPS of $1.05.
Backlog totaled $3.9 billion extending through 2040, split between $3.1 billion in LEU and $0.8 billion in Technical Solutions, including $700 million of broker-dealer backlog.
The company secured a $900 million Department of Energy HALEU enrichment award, pending final negotiation, with potential to exceed $1 billion.
A $560 million expansion investment is underway with new partnerships aimed at cost reduction and operational efficiencies, though progress remains in early stages.

LeMaitre Vascular, Inc.

LMAT Q1 2026

Reported: 2026-05-07

LeMaitre Vascular’s shares fell 3.7% post-earnings, reflecting investor disappointment despite solid sales and EPS growth, driven primarily by cautious gross margin guidance and deceleration in unit growth within the distribution business.

Key takeaways

Sales grew 11% in Q1, driven by an 8% price increase and 2% unit growth, with direct organic sales growing 12.8%; however, the distribution segment saw lower-than-average unit performance, weighing on growth.
Gross margin improved 350 basis points year-over-year to 72.7%, but Q2 guidance lowered margins to 72.1% due to new warehouse and tissue processing transfers, signaling near-term margin pressure.
Operating expenses rose 6% to $30.6 million despite a 3% overall headcount reduction; operating income increased 41% to $17.8 million with a 27% operating margin.
EPS grew 42% to $0.68, boosted by margin expansion and a structurally lower tax rate due to higher foreign-derived intangible income deductions.
Full-year revenue guidance affirmed at $280 million for 12% organic growth, but margin guidance only modestly raised, underscoring cautious outlook amid ongoing operational transitions.

Limbach Holdings, Inc.

LMB Q1 2026

Reported: 2026-05-07

Limbach’s shares dropped sharply by 35% as investors reacted negatively to organic revenue decline, continued margin compression, and cautious outlook despite strong bookings and stable adjusted EBITDA.

Key takeaways

First quarter revenue grew 4.3% to $138.9 million but organic revenue fell 13.4%, reflecting prior booking softness and seasonal weakness.
ODR segment revenue increased 10.4%, yet organic ODR revenue declined 5.4%; gross margin contracted to 22.4% due to lower fixed cost absorption and absence of prior year project write-ups.
Adjusted EBITDA of $8.7 million met expectations, but cash flow was negative due to lower net income and elevated working capital needs.
Bookings were robust at $209 million with a 1.5x book-to-bill ratio, driven by strength in data centers (27% of bookings) and health care verticals.
Management emphasized strategic investments in sales enablement, vertical market teams, and customer solution offerings but provided a guarded outlook amid organic growth headwinds and margin pressure.

Louisiana-Pacific Corporation

LPX Q1 2026

Reported: 2026-05-07

The 8.2% stock gain reflects investor approval of stronger-than-expected price realization in Siding and OSB segments, which offset volume declines and led to EBITDA performance above the high end of guidance despite ongoing headwinds.

Key takeaways

EBITDA reached $82 million, supported by price gains in Siding and OSB exceeding expectations.
OSB pricing softness reduced net sales and EBITDA by $66 million, driven by weak demand and below-breakeven prices.
Siding EBITDA declined only $5 million despite a 10% drop in net sales, aided by the growth of the higher-margin ExpertFinish product line (12% of Siding volume; 18% of revenue).
Channel inventories normalized in Q2 following elevated prebuy activity, particularly in off-site construction.
The company secured new partnerships with two national homebuilders, aiming to supply 100 million square feet to 15 of the top 25 builders, highlighting potential for market share gains.

Lantronix, Inc.

LTRX Q3 2026

Reported: 2026-05-07

Lantronix shares fell 15.5% as investors reacted negatively to signs of margin pressure despite solid revenue growth, and cautious outlook commentary that tempered enthusiasm for the unmanned systems segment.

Key takeaways

Revenue came in at $30.2 million, aligned with guidance, supported by a 22% year-over-year increase in the Embedded IoT Solutions portfolio.
Non-GAAP EPS was $0.04, within guidance but underscoring modest profitability given revenue scale.
Gross margin held above 43%, aided by a richer product mix, but investors evidently questioned sustainability amid rising investments.
Management highlighted expanding R&D and sales efforts to capitalize on growth in unmanned systems and counter-drone markets, suggesting increased spending that may weigh on future margins.
While the strategic shift into edge AI and broader drone applications is promising, cautious outlook signals and potential margin compression likely pressured the stock.

Lumen Technologies, Inc.

LUMN Q1 2026

Reported: 2026-05-07

Shares rose 5.1% as Lumen’s ongoing strength in programmable network adoption and significant customer wins indicate better-than-expected traction, particularly in NaaS growth and multi-cloud connectivity innovation.

Key takeaways

Q1 revenue and EBITDA came in line with expectations, reflecting steady core execution.
Customer adoption of NaaS services increased notably: 25% growth in adoption, 35% growth in active ports, and 32% growth in active services quarter-over-quarter.
Secured major contracts including a 600-site upgrade with a global financial services firm and a 300-site deployment with a global logistics company.
Announced intent to acquire Alkira, which will expand Lumen’s programmable network capabilities into East-West connectivity and cloud ecosystems.
Strategic partnerships with AWS and Google emphasize Lumen’s position in direct cloud on-ramps and digital fabric solutions tailored for AI-driven enterprise needs.

Marriott International, Inc.

MAR Q1 2026

Reported: 2026-05-07

Marriott’s stock declined modestly by 0.8% following the Q1 2026 earnings report, reflecting investor caution despite modest RevPAR growth and a raised full-year guidance, likely due to ongoing geopolitical risks and a cautious outlook on regional performance.

Key takeaways

Global RevPAR increased 4.2% year-over-year, with the U.S. and Canada up 4%, led by nearly 7% growth in luxury and 3.5% in select service segments.
International RevPAR rose 4.6%, driven by strong increases in APAC (+7%) and Greater China (nearly +6%), offset partly by Middle East weakness where March RevPAR fell over 30%.
Full-year global RevPAR guidance was raised to 2% to 3% growth, indicating tempered expectations amid geopolitical uncertainty.
Development remained robust with record first-quarter global signings up 9% year-over-year and a record pipeline of nearly 618,000 rooms, with 43% under construction.
Continued investment in technology and AI aims to improve customer engagement and operational efficiency, though these initiatives are early-stage and the impact remains to be seen.

Madrigal Pharmaceuticals, Inc.

MDGL Q1 2026

Reported: 2026-05-07

The stock gained 6.4% post-earnings, reflecting investor approval of strong net sales growth driven by accelerating Rezdiffra adoption and a rapidly expanding addressable market in MASH.

Key takeaways

Q1 2026 net sales reached $311 million, up 127% year-over-year.
Active Rezdiffra patients grew to over 42,250, a 2.5x increase from Q1 2025.
The U.S. diagnosed MASH market expanded nearly 50% since 2023, now estimated at 460,000 patients.
Rezdiffra penetration remains below 10%, underscoring significant runway ahead.
Management highlighted a robust data generation strategy with upcoming presentations reinforcing efficacy and cardiovascular risk benefits.

Magnite, Inc.

MGNI Q1 2026

Reported: 2026-05-07

Magnite’s shares rose modestly by 2.9% following Q1 results that delivered mixed outcomes: while CTV growth and margin expansion were encouraging, DV+ continued its decline, tempering investor enthusiasm.

Key takeaways

Total revenue beat expectations, driven by strong growth in CTV, with CTV contribution ex-TAC increasing 30% and representing 51% of total revenue.
DV+ revenue declined 5%, a deceleration though better than anticipated, reflecting ongoing shifts in ad budgets toward streaming formats.
Adjusted EBITDA exceeded consensus by $5 million, aided by earlier-than-expected cost efficiencies contributing to margin expansion.
Top 10 accounts grew by mid-30% year-over-year, while the remaining base grew in the mid-20s, indicating broad-based demand strength.
AI integration into the platform is advancing automation and efficiency, but its impact remains in early stages.

MannKind Corporation

MNKD Q1 2026

Reported: 2026-05-07

MannKind’s shares surged 24.1% following the quarter, driven by positive developments in its strategic partnership with United Therapeutics, clear regulatory progress for Afrezza Pediatrics, and encouraging early demand trends for FURO6 despite a seasonally soft Q1 revenue performance.

Key takeaways

Q1 revenues rose 15% year-over-year to $90 million, now including FURO6 contributions, though seasonally impacted by deductible resets causing lower fills and dose-per-prescription declines (~20% for FURO6 vs Q4).
The expanded agreement with United Therapeutics brought an immediate $5 million payment and potential milestones totaling $35 million plus royalties, signaling validation of MannKind’s Technosphere platform.
FURO6 demand indicators were positive, with record prescriber counts and a nearly 60% increase in doses dispensed through April compared to last year, suggesting momentum ahead of the Q3 auto-injector launch.
Integration of SC Pharma is substantially complete, with identified synergies already exceeding the initial $20 million annual target, strengthening the company’s commercial infrastructure.
FDA approval of an updated Afrezza label now includes clear dosing guidance to support the upcoming pediatric launch, positioned as a key near-term catalyst with a PDUFA date set for May 29.

Marathon Petroleum Corporation

MPC Q1 2026

Reported: 2026-05-07

Shares fell 2.7% following Marathon Petroleum’s earnings, reflecting investor caution despite operational execution, as the lack of updated guidance and margin pressures weighed on sentiment.

Key takeaways

Refinery utilization reached 89% with nearly 100% capture, marking strong operational performance and lowest unplanned downtime in a decade.
Adjusted EPS was $1.65 and adjusted EBITDA hit $2.8 billion, supported primarily by the Refining & Marketing segment.
Refining & Marketing adjusted EBITDA per barrel was $5.37, with turnaround costs of $530 million reflecting ongoing maintenance.
The company maintained its full-year turnaround cost outlook at $1.35 billion and returned over $1 billion to shareholders, including $750 million in share repurchases.
Despite geopolitical disruptions tightening global markets and supporting demand, no revision to full-year guidance was communicated, which likely underpinned investor caution.

MPLX LP

MPLX Q1 2026

Reported: 2026-05-07

Shares declined 2.6% after MPLX reported softer-than-expected volume trends and margin pressures, despite ongoing capital investments and operational progress. The market appears cautious on headwinds from reduced pipeline and fractionation volumes, hedge mark-to-market losses, and elevated operating expenses.

Key takeaways

Crude Oil and Products Logistics segment EBITDA increased by $14 million year-over-year, helped by higher rates but offset by a 4% decline in both pipeline and terminal volumes due to refinery turnarounds.
Gathering and Processing segment EBITDA fell $42 million year-over-year, impacted by a $45 million drag from prior year divestitures, lower NGL prices, higher operating expenses, and the absence of a one-time $37 million customer agreement benefit in 2025.
Gathering volumes rose 10% excluding noncore divestitures, driven by continued growth in Utica and Permian regions; processing volumes increased 2%, with Marcellus utilization steady at 94%.
Total fractionation volumes declined 3%, mainly from lower ethane recovery tied to elevated regional gas prices, while weather disruptions (Winter Storm Fern) imposed a roughly $13 million headwind.
Hedging activities resulted in a $56 million negative mark-to-market in Q1, expected to unwind over the year, and project-related expenses anticipated to rise $50 million sequentially in Q2 due to seasonality.

Millrose Properties, Inc.

MRP Q1 2026

Reported: 2026-05-07

Millrose Properties shares fell 10.7% after the earnings release, reflecting investor disappointment likely tied to cautious near-term demand indicators and margin pressures in the homebuilding sector, despite stable recurring earnings and capital deployment.

Key takeaways

Invested capital rose modestly to $8.7 billion from $8.5 billion last quarter, with 95% pooled capital maintaining disciplined deployment.
AFFO increased to $125.9 million, up on a per-day basis despite a shorter quarter, underscoring recurring and contractual income stability.
Diversification improved with 17 counterparties, including 31% of the portfolio outside the core Lennar agreement, broadening exposure beyond a single relationship.
Management highlighted ongoing margin compression (200 to 500 basis points) and cautious builder behavior amid rate volatility and geopolitical uncertainty, contributing to a choppy demand environment.
Credit facility amendments enhanced liquidity and flexibility with $1.8 billion unsecured capacity and $1.5 billion quarter-end liquidity, supporting future capital deployment.

MicroStrategy Incorporated

MSTR Q1 2026

Reported: 2026-05-07

The stock rose modestly by 1.6%, reflecting a quarter dominated by unrealized Bitcoin losses and operating losses driven by Bitcoin price declines, with no clear upside surprise to significantly uplift investor sentiment.

Key takeaways

Reported operating loss of $14.5 billion and net loss of $12.8 billion primarily due to mark-to-market Bitcoin price decline.
Bitcoin holdings increased to 818,334 BTC, representing 3.9% of total supply, acquired at an average cost of ~$76,000 per Bitcoin.
Bitcoin per share grew 18% year-over-year to 213,371 as of May 2026, highlighting ongoing accumulation efforts.
Purchased 89,599 Bitcoin in Q1 at an average price of $80,900, and an additional 56,235 coins in Q2 at around $73,400.
Balance sheet remains highly liquid with $2.2 billion in cash and net leverage at a modest 9.3%, supported by $13.5 billion preferred equity and $8.2 billion convertible debt.

Myriad Genetics, Inc.

MYGN Q1 2026

Reported: 2026-05-07

Shares dropped 16.8% following the quarter, reflecting investor disappointment with margin compression and cautious outlook despite steady revenue growth and reaffirmed guidance.

Key takeaways

Q1 revenue of just over $200 million came within guided range, driven by 10% and 16% growth in hereditary cancer testing volumes in affected and unaffected populations, respectively.
GeneSight mental health test volume grew 7% year-over-year, marking the fourth consecutive quarter of mid-to-high single-digit growth.
Prenatal testing volumes declined year-over-year but management targets a recovery in the second half of 2026.
Gross margin held at 69%, consistent with full-year expectations, but adjusted EBITDA loss of $4.5 million and EPS loss of $0.09 signal margin pressure amid significant commercial and R&D investments.
The company reaffirmed 2026 guidance, expecting low single-digit sequential revenue growth and positive adjusted EBITDA, but cautious outlook and ongoing investments weighed on investor sentiment.

NRG Energy, Inc.

NRG Q1 2026

Reported: 2026-05-07

Shares declined 10% following the earnings release, driven by investor disappointment over a cautious near-term outlook amid a soft market environment and decelerating demand growth in key regions.

Key takeaways

Texas experienced a notably mild winter with heating degree days down 30% year-over-year, suppressing power demand and limiting market opportunities.
The company reaffirmed its 2026 guidance, but emphasized near-term variability and a cautious stance on power demand growth despite a structurally improved market outlook.
Integration of the LS Power portfolio is underway as expected, with new Texas Energy Fund projects on track to come online, though these are positioned as upside optionality rather than core growth drivers.
Management highlighted incremental capacity upgrade opportunities totaling up to 2 gigawatts, to be pursued selectively based on capital discipline and customer commitments.
While long-term demand shows promise, investors focused on the slower-than-anticipated recovery and evolving regulatory challenges impacting load growth timing and magnitude.

Novavax, Inc.

NVAX Q1 2026

Reported: 2026-05-07

Shares rose 14.0% as the market rewarded Novavax’s clear progress in expanding high-value partnerships, particularly with big pharma like Pfizer and Sanofi, signaling confidence in its capital-efficient, licensing-driven growth strategy rather than direct product sales.

Key takeaways

Novavax signed four new material transfer agreements (MTAs) including a significant oncology MTA with a top 10 global pharma company, marking expanded collaboration in difficult cancer targets.
The company’s partnerships with Pfizer and Sanofi are positioned to generate billions in future milestone and royalty revenues, with Sanofi already contributing over $800 million in revenue to date.
Strategy emphasizes capital-efficient growth by leveraging partners’ infrastructure and investment, reducing Novavax’s operational costs while focusing on R&D-led innovation.
Management outlined a lean operating model aimed at driving down costs while supporting key R&D capabilities under new Head of R&D Bob Walker.
The outlook centers on advancing current partnerships to clinical readiness and converting MTAs into licensing agreements, supporting long-term, diversified revenue streams.

Navitas Semiconductor Corporation Common Stock

NVTS Q1 2026

Reported: 2026-05-07

Shares dropped 10% as investors reacted to cautious outlook signals and margin pressures despite sequential revenue growth—concerns surfaced around the sustainability of the transformation and potential margin compression from shifting product mix.

Key takeaways

Revenue grew 18% sequentially, driven by a 25% year-over-year increase in high-power markets, marking a return to growth after restructuring.
High-power business now constitutes a majority of total revenue, reflecting the strategic pivot away from mobile and low-end consumer segments.
Management highlighted accelerating demand from AI data centers and grid modernization as key growth drivers, projecting a $3.5 billion TAM by 2030 with a combined 60% CAGR.
Despite revenue gains, investors likely reacted negatively to muted margin commentary and the emphasis on “gradual” margin expansion, implying potential margin compression risks amid product mix transition.
The cautious tone on scaling new GaN and SiC products and ongoing qualification cycles suggests uncertainty around near-term execution and ramp timelines, weighing on investor confidence.

The New York Times Company

NYT Q1 2026

Reported: 2026-05-07

The New York Times shares rose 3.8% following a quarter that delivered solid digital subscription growth and a notable acceleration in digital advertising revenue that surpassed expectations.

Key takeaways

Digital-only subscription revenues grew approximately 16%, with 310,000 net new digital-only subscribers added, pushing the total base beyond 13 million.
Total subscription revenues rose 11.3% to about $517 million, coming in above the company’s guidance range.
Digital advertising revenues surged 32%, reflecting strong execution and marked improvement over prior periods.
Adjusted operating profit (AOP) increased roughly 27%, with margin expansion of 200 basis points, underscoring disciplined cost management alongside strategic investments.
The company continues to invest in premium journalism, video content, and new product innovations such as games and podcasts to drive long-term engagement and growth.

Oscar Health, Inc.

OSCR Q1 2026

Reported: 2026-05-07

Oscar Health's shares surged 16.3% following a quarter that clearly outperformed expectations, driven by robust membership growth and significant margin expansion, with management reaffirming full-year guidance despite cautious risk assumptions.

Key takeaways

Revenue grew 53% year-over-year to $4.6 billion, reflecting strong top-line expansion.
Membership increased 56% year-over-year to 3.2 million, underscoring strong demand and retention in the individual market.
SG&A ratio improved by 60 basis points to 15.2%, aided by disciplined expense management and growing AI efficiencies.
Medical Loss Ratio (MLR) improved 490 basis points year-over-year to 70.5%, with utilization roughly in line with expectations.
Operating earnings rose nearly 2.5x year-over-year to $704 million, supporting management’s outlook for meaningful profitability in 2026.

One Stop Systems, Inc.

OSS Q1 2026

Reported: 2026-05-07

Shares surged 54.6% on the back of outsized revenue growth and robust bookings, driven by accelerating demand in defense and commercial markets as well as a sharpened strategic focus post divestiture.

Key takeaways

Revenue rose 55% year-over-year to $8.1 million, reflecting growth across defense and commercial segments.
First quarter bookings hit nearly $15 million, nearly matching total 2023 bookings, with a book-to-bill ratio of 1.8 indicating strong future revenue visibility.
Notable program wins include $10.5 million from U.S. Navy and prime contractors supporting the P-8 Poseidon aircraft and new commercial engagements in aerospace, robotics, and autonomous energy data centers.
The divestiture of Bressner ($22.4 million proceeds) has refocused OSS on higher-margin AI compute platforms for edge applications, simplifying operations and strengthening the balance sheet.
Average order size nearly tripled since 2023, with bookings increasingly tied to multiyear, larger commitments across an expanding customer base.

Occidental Petroleum Corporatio

OXY Q1 2026

Reported: 2026-05-07

Occidental Petroleum’s shares fell 9.1% following the quarter, driven primarily by cautious forward guidance amid ongoing market volatility and geopolitical uncertainty. Investor disappointment centered on deceleration signals in key segments and a guarded outlook that weighed on confidence despite stable operational execution.

Key takeaways

The company maintained a disciplined capital program aligned with its 2026 plan, emphasizing balance sheet strength and sustainability of returns.
Production growth was steady, with a reported increase to over 1.4 million BOE per day since 2015, though no clear acceleration was highlighted this quarter.
The portfolio remains predominantly domestic, with 83% of production and 88% of resources in the U.S., reflecting strategic focus on stability.
Reserve replacement ratio has been consistently above 100% since 2016, supporting resource durability; however, forward-looking comments were cautious regarding market volatility.
Leadership transition announced, with CEO Vicki Hollub retiring in June and COO Richard Jackson taking over, signaling continuity in the company’s operational and strategic approach.

Par Pacific Holdings, Inc.

PARR Q1 2026

Reported: 2026-05-07

Shares fell 10% as investors reacted negatively to visible deceleration in refining segment EBITDA and cautious second-quarter throughput outlook amid planned outages and seasonally lower volumes.

Key takeaways

Adjusted EBITDA declined to $91 million with refining segment EBITDA down to $69 million from $88 million in the prior quarter, signaling operational and margin pressures.
Planned maintenance in Washington and the upcoming Hawaii turnaround are expected to reduce second-quarter throughput materially, with system-wide midpoint guidance falling to 182,000 barrels per day from a first-quarter record of 184,000 barrels per day.
Retail segment same-store fuel and in-store sales declined 3.3% and 1% respectively, reflecting consumer hesitation amid rising flat fuel prices and state-level retail closures due to flooding.
Despite exceptionally strong crack spreads in Asia and robust market conditions, exposure remains limited with no hedges in place and some margin pressure on production costs—especially in Washington and Wyoming.
Capital allocation included $28 million in share repurchases during the quarter, supporting shareholder returns even as near-term operational headwinds weigh on growth momentum.

Paycom Software, Inc.

PAYC Q1 2026

Reported: 2026-05-07

Paycom’s stock rallied 5.1% after earnings, driven by solid revenue growth and expanding margins that reinforced confidence despite conservative full-year guidance.

Key takeaways

Total revenues rose 8% year-over-year to $572 million in Q1 2026, with recurring and other revenue up 9%.
Adjusted EBITDA margin expanded by 50 basis points year-over-year, reaching 48.2%, reflecting operational efficiencies from automation.
GAAP net income was $156 million, or $3.04 per diluted share; non-GAAP net income was $161 million, or $3.15 per diluted share.
Management reaffirmed full-year 2026 revenue guidance of $2.175–$2.195 billion (~6.5% growth) and adjusted EBITDA targets, signaling steady but cautious outlook.
Aggressive capital return initiatives included repurchasing 15% of shares outstanding in Q1 and a new $2 billion buyback authorization.

Pitney Bowes Inc.

PBI Q1 2026

Reported: 2026-05-07

Pitney Bowes delivered an essentially in-line quarter as reflected by a modest +0.2% stock move post-earnings, indicating investor uncertainty amid early signs of stabilization in key segments but without clear upside momentum.

Key takeaways

SendTech showed tentative signs of improvement, with management focusing on slowing meter declines through enhanced retention efforts and predictive analytics, alongside a clearer go-to-market strategy.
Shipping software growth initiatives include product simplification and greater customer-centric innovation, though returns from these efforts remain to be seen.
Presort segment continues to expand via tuck-in acquisitions, now supported by external advisory engagement to accelerate deal flow, yet no shift toward larger deals was confirmed.
Pitney Bowes Bank is progressing on operational improvements, but no explicit financial updates or impact were provided in this call.
Capital allocation remains active with dividends and share repurchases, but strategic review is in early phases without update on potential outcomes or timeline.

Public Service Enterprise Group Incorporated

PEG Q1 2026

Reported: 2026-05-07

Shares declined 1.4% following a modestly mixed quarter with steady guidance, as investors appeared cautious despite solid operational execution and stable full-year earnings expectations.

Key takeaways

Reported Q1 non-GAAP operating earnings of $1.55 per share, maintaining full-year guidance range of $4.28 to $4.40 per share.
Utility segment demonstrated strong operational reliability amid severe winter weather, including rapid restoration of power outages within 24 hours.
PSEG Power offset the end of a zero emission certificate program with higher gas volume and capacity revenues, supporting stable results.
Continued capital investments of approximately $4.2 billion planned for 2026, focusing on infrastructure modernization and energy efficiency programs.
Regulatory developments such as FERC’s favorable transmission cost allocation ruling hold potential to reduce customer bills through refunds.

Pfizer Inc.

PFE Q1 2026

Reported: 2026-05-07

Pfizer's shares were little changed, rising 0.9% after earnings as the company's quarterly results and outlook broadly met market expectations without providing a clear catalyst for a larger move.

Key takeaways

Total revenues and adjusted diluted EPS exceeded internal expectations, supporting steady near-term financial performance.
Launched and acquired products grew 22% operationally, with oncology (notably Seagen) achieving 20% year-over-year revenue growth.
Nurtec contributed 41% operational growth, driven by strong demand across acute and preventive migraine treatments.
Progress on R&D remains on track, with three positive Phase III readouts and plans for approximately 20 pivotal study starts in 2026.
Legal developments, including Vyndamax patent settlements and a favorable Belgian court ruling on Comirnaty contracts, enhance long-term growth visibility and cash flow prospects.

Koninklijke Philips N.V.

PHG Q1 2026

Reported: 2026-05-07

Philips shares gained modestly (+2.7%) following a quarter that largely met expectations, supported by steady order intake and margin expansion, though market reaction suggests investors were cautious on incremental upside.

Key takeaways

Order intake rose 6%, driven by strength in North America and disciplined growth across Diagnostic & Therapeutic (D&T) and Connected Care segments.
Comparable sales increased 4% with broad-based growth in Personal Health and sustained momentum in key imaging modalities such as MRI and CT.
Adjusted EBITDA margin expanded by 40 basis points to 9%, despite inflationary pressures including higher tariffs.
Innovation momentum continued with 20 FDA clearances/pre-market approvals, notably delivering AI-enabled solutions in cardiac MRI, spectral CT, and image-guided therapy.
Management reiterated full-year guidance reflecting confidence in execution amidst ongoing macro uncertainty, but the market’s tempered response implies vigilance on competitive and geopolitical risks.

Koninklijke Philips N.V.

PHIA.AS Q1 2026

Reported: 2026-05-07

The 3.7% stock gain reflects investor approval of Philips’ solid order intake growth, expanding margins, and clear execution on innovation, despite ongoing macro uncertainties.

Key takeaways

Order intake rose 6% in Q1, led by equipment growth in Diagnostic & Treatment (D&T) and Connected Care segments.
Comparable sales increased 4%, driven by broad-based segment contributions and particularly strong personal health performance.
Adjusted EBITDA margin expanded by 40 basis points to 9%, marking the sixth consecutive quarter of margin improvement despite inflationary pressures such as higher tariffs.
Innovation momentum remains strong, with 20 FDA 510(k) clearances and premarket approvals—more than doubling year-over-year—including AI-driven solutions in MRI, CT, and Image Guided Therapy.
North America and Europe sustained leadership in growth, supported by enterprise partnerships and expanded retail distribution channels globally.

Powell Industries, Inc.

POWL Q2 2026

Reported: 2026-05-07

The stock surged 18.7% following Powell Industries’ earnings report, driven by stronger-than-expected order growth and backlog expansion supported by significant mega project awards and healthy activity across multiple end markets.

Key takeaways

New orders reached $490 million in the quarter, contributing to a midyear total of nearly $1 billion in awards.
Backlog grew 12% sequentially and 33% year-over-year to $1.8 billion, providing visibility well into fiscal 2028.
Two mega projects awarded this quarter exceeded $75 million each, with an additional $400 million mega project announced post-quarter that is now the company’s largest ever.
Revenue increased 6% year-over-year, with gross margin maintained at 29.6%, reflecting continued solid project execution.
Business diversification across electric utility (30% of backlog), oil and gas (29%), and commercial/industrial/data centers (29%) is reducing cyclicality and supporting capacity expansion efforts.

Primoris Services Corporation

PRIM Q1 2026

Reported: 2026-05-07

Shares plunged 46.8% as investors reacted sharply to renewed margin compression and execution challenges in the solar renewables segment, alongside downward revisions to timing and revenue recognition that undermined 2026 guidance.

Key takeaways

Solar projects faced significant cost pressures due to labor issues, project redesigns, and weather disruptions, leading to lower gross profit and compressed margins.
Timing of new project bookings shifted later, pushing expected 2026 Renewables revenue down to approximately $2.3 billion.
Management attributed issues to early planning and new geographic labor market complexities but acknowledged they originated from projects executed in 2024.
Utility segment showed sequential strength with improving margins and top-line growth, particularly driven by gas operations and power delivery activities.
Pipeline services and industrial energy operations delivered growth and margin improvement, but meaningful recovery and backlog conversion are expected primarily in 2027 and beyond.

Prudential Financial, Inc.

PRU Q1 2026

Reported: 2026-05-07

Prudential’s shares declined 0.8% following the quarter as modest earnings growth was partially offset by lingering challenges in fixed income and real estate asset classes, as well as continued pressure from annuity runoff and cautious outlook on certain segments.

Key takeaways

Adjusted operating income grew 10% year-over-year to $1.6 billion, with a 15% adjusted operating return on equity.
PGIM showed solid earnings growth, aided by private assets deployment ($13 billion, with ~$5 billion in direct lending and asset-backed finance) and a near doubling of active ETF retail AUM to nearly $30 billion.
Total third-party net inflows at PGIM improved sequentially to nearly $2 billion despite ongoing active equity outflows; affiliated net outflows of $1.9 billion were primarily due to annuity runoff.
Prudential continues to exit non-scale markets (Taiwan, India, Kenya, Indonesia) to redeploy capital toward higher-return areas.
CEO highlights progress on strategic priorities but acknowledges challenges in Japan and a competitive landscape putting pressure on some asset classes and product lines.

Restaurant Brands International Inc.

QSR Q1 2026

Reported: 2026-05-07

Restaurant Brands International's shares fell 3.1% following the Q1 report, primarily reflecting investor disappointment with the cautious outlook and signs of deceleration in key growth metrics that contrasted with the upbeat tone of management’s commentary.

Key takeaways

Comparable sales grew 3.2% system-wide and 6.2% on a system-wide basis, with Burger King U.S. comp sales up nearly 6%.
Tim Hortons reported modest 1.5% comparable sales growth in Canada amid a challenging consumer environment, with beverage sales up 2%, led by cold beverages (+10%) and espresso/tea (+8%).
International segment yielded 5.7% comp sales growth and 4.5% net restaurant growth, supporting 11.1% system-wide sales increase.
Management resumed share repurchases for the first time in over two years and targeted consistent double-digit total shareholder returns.
Despite operational progress and innovation pipelines, the market appears cautious on growth sustainability and margin pressure risks going forward.

Quanterix Corporation

QTRX Q1 2026

Reported: 2026-05-07

Quanterix shares dropped 16.7% after earnings as investors reacted negatively to softer-than-expected instrumentation sales and a cautious near-term outlook, despite ongoing investments and operational changes that have yet to deliver clear growth.

Key takeaways

Q1 revenue totaled $36.4 million, with consumable sales meeting plans but instrumentation revenue coming in below expectations.
Management attributed weaker instrument sales partially to timing issues but acknowledged the need for sharper sales focus and commercial investments.
The company is increasing investments in leadership and go-to-market capabilities to drive pharma partnerships and new business development.
Gross margins and cash usage targets were maintained, reflecting operational discipline despite top-line pressures.
Quanterix emphasized long-term growth initiatives, particularly in Alzheimer’s diagnostics, but these remain early-stage without immediate financial impact.

Rigel Pharmaceuticals, Inc.

RIGL Q1 2026

Reported: 2026-05-07

Shares fell 6.6% after earnings as investors reacted negatively to the persistent first-quarter reimbursement challenges and seasonally impacted sales, signaling caution despite management's maintained full-year guidance.

Key takeaways

Q1 2026 net product sales reached $54.9 million, up 26% year-over-year but pressured by typical seasonal reimbursement dynamics affecting January and February volumes.
TAVALISSE sales grew 31% year-over-year to $37.3 million, aided by both stronger demand and improved gross-to-net adjustments.
GAVRETO sales increased 7% to $9.6 million, establishing itself as a stable portfolio contributor.
REZLIDHIA generated $8 million in net product sales, continuing growth momentum.
Management reiterated 2026 revenue guidance of $275 million to $290 million and forecasted net income profitability, though near-term demand headwinds weighed on investor sentiment.

Rockwell Automation, Inc.

ROK Q2 2026

Reported: 2026-05-07

Rockwell Automation's shares climbed 14.7% following an earnings report that beat expectations across sales, margins, and EPS, driven by robust growth in multiple key segments and accelerating demand recovery.

Key takeaways

Organic sales rose 9% year-over-year with reported sales up 12%, including a positive 3-point currency impact.
Intelligent Devices segment grew 9% organically, led by Motion, I/O, and Safety & Sensing businesses, and expanding applications for OTTO autonomous mobile robots.
Software & Control saw 17% organic growth, fueled by strong Logix sales and notable wins in data center automation.
Lifecycle Services declined 1% organically, reflecting customer deferral of larger projects but continued smaller-scale investments.
Enterprise operating margin reached 22.5%, with adjusted EPS at $3.30, both well above expectations due to volume gains, pricing, mix improvement, and productivity efforts.

Royalty Pharma plc

RPRX Q1 2026

Reported: 2026-05-07

Royalty Pharma’s shares declined modestly by 0.5% following an earnings report that showed steady growth but lacked new positive catalysts to drive the stock higher. While the company reiterated double-digit portfolio growth and raised full-year guidance, investors appeared cautious given the absence of upside surprises.

Key takeaways

Portfolio receipts grew 10% year-over-year, driven by diversified asset base; recurring royalty receipts increased 13%.
Returned capital efficiently with returns on invested capital around 14% and invested equity near 20%.
Deployed over $0.5 billion in capital including $1.25 billion in announced transactions on three therapies; also repurchased 1 million shares and raised dividend by 7%.
Highlighted progress in R&D co-funding with large biopharma partners such as J&J and Teva, illustrating a strategic shift toward synthetic royalties and innovative funding structures.
Incremental full-year guidance was raised, supported by a pipeline of clinical and regulatory developments, though the market reaction suggests limited incremental confidence.

Schrodinger, Inc.

SDGR Q1 2026

Reported: 2026-05-07

Shares were essentially unchanged, rising 0.6% post-earnings, reflecting a mixed reception to Schrodinger’s first quarter 2026 results and guidance with steady execution but no clear upside catalyst.

Key takeaways

Annual Contract Value (ACV) grew 12% year-over-year to $28.4 million, driven by scale-up with top 20 pharma customers and new products.
Total revenue reached $58.6 million, with software revenue at $35.6 million, including 34% from hosted licenses, up from 24% last year, reflecting an ongoing transition.
Drug discovery revenue contributed $23 million, supported by collaborations and equity stakes such as the recent Lilly acquisition of Ajax Therapeutics.
Management emphasized innovation, highlighting the upcoming Bunsen AI co-scientist launch to potentially transform molecular discovery workflows.
Despite positive operational momentum, the market appears cautious amid macroeconomic uncertainty and no major beat or outlook raise, keeping the stock reaction muted.

SLR Investment Corp.

SLRC Q1 2026

Reported: 2026-05-07

SLR Investment Corp. shares fell sharply 14.5% as investors reacted negatively to sequential net investment income decline driven by slowing new deal activity, lower fee income, and a cautious outlook amid economic and AI-related uncertainties.

Key takeaways

Net investment income (NII) was $0.33 per share, declining sequentially due to a lag from the Fed’s rate cut, contracting portfolio size, and reduced fee income.
Quarter-end portfolio was $3.2 billion, down on net repayments of $180 million amid subdued deal activity in a seasonally light and uncertain environment.
Approximately 85% of the portfolio is in senior secured specialty finance loans, the highest on record, reflecting a defensive, collateral-based strategy.
Net asset value per share declined slightly sequentially to $18.16 but was flat year-over-year.
Management acknowledged challenges from rising geopolitical risks and AI-driven disruption concerns, maintaining a cautious tone on outlook and portfolio risk recalibration.

Super Micro Computer, Inc.

SMCI Q3 2026

Reported: 2026-05-07

The stock surged 24.1% following the quarter, driven by a significant gross margin recovery and clear progress in expanding high-value data center solutions, signaling investor confidence in the company’s strategic transformation and operational improvements.

Key takeaways

Fiscal Q3 revenue reached $10.2 billion despite short-term customer site readiness delays impacting timing of some deployments.
Non-GAAP gross margin rose sharply to 10.1%, a 58% increase quarter-over-quarter, reflecting better product mix, cost management, and supply chain efficiency.
The Data Center Building Block Solutions (DCBBS) segment is growing steadily and becoming a larger profit driver by offering integrated AI factory solutions.
Order backlogs hit record highs, underscoring strong demand and market expansion in NeoCloud, sovereign AI, and enterprise segments.
Supply chain and tariff cost pressures were actively managed through automation, yield improvements, and inventory controls, supporting margin sustainability.

Sollensys Corp.

SOLS Q1 2026

Reported: 2026-05-07

Solstice’s stock declined 6.9% following the quarter, reflecting investor disappointment with margin compression due to refrigerant mix and elevated R&D spending, despite top-line growth and solid cash flow.

Key takeaways

Net sales increased 10% year-over-year to $991 million, driven by robust demand in Electronic Materials and Refrigerants & Applied Solutions segments.
Adjusted EBITDA was flat year-over-year at $249 million, with a 25.1% margin, down primarily due to a mix shift toward lower-margin refrigerants and higher R&D investments.
GAAP net income declined to $85 million, impacted by higher SG&A and interest expenses as a stand-alone public company.
Adjusted diluted EPS came in at $0.63 for the first quarter.
Free cash flow totaled $124 million, despite a significant rise in growth CapEx, including a $200 million investment to expand sputtering target capacity.

Sarepta Therapeutics, Inc.

SRPT Q1 2026

Reported: 2026-05-07

Shares fell 4.5% after the earnings release as investors reacted negatively to cautious ELEVIDYS growth commentary and a reiterated full-year guidance range that lacked upward revision amid ongoing commercial ramp challenges.

Key takeaways

Total net product revenue reached $331 million, including $229 million from PMO therapies and $102 million from ELEVIDYS.
Management emphasized stabilization of marketed products but highlighted the gradual path from patient consideration to infusion for ELEVIDYS.
Full-year ELEVIDYS revenue guidance was reiterated at $1.2 billion to $1.4 billion, signaling no acceleration despite evidence of clinical benefit.
Financial position remains solid, with approximately $748 million in cash and investments and positive GAAP and non-GAAP earnings.
Pipeline progress continues, especially with siRNA programs in DM1, FSHD, and Huntington’s disease, although meaningful impacts remain on the horizon.

Strata Critical Medical, Inc.

SRTA Q1 2026

Reported: 2026-05-07

Strata’s shares rallied 10.8% following a quarter marked by robust revenue growth driven by Logistics and new Clinical business lines, alongside positive signs of improving cash flow and an active M&A pipeline that exceeded investor expectations.

Key takeaways

Reported 87% year-over-year revenue growth, led by 32% organic growth in Logistics and strong contributions from the new Clinical segment.
Generated operating and free cash flow before aircraft acquisitions for the first time this quarter, indicating improved earnings quality.
Announced a new acquisition of Ohio Valley Perfusion Associates, aligned with a broader M&A strategy targeting fragmented markets with mid-single-digit EBITDA multiples.
Expanded logistics footprint with a new base in Chicago and a total fleet of 10 owned aircraft plus 35 dedicated, enhancing national service coverage.
Industry trends toward increased adoption of NRP and third-party surgical recovery have offset declines in donor volume, supporting demand for Strata’s integrated platform.

SSR Mining Inc.

SSRM Q1 2026

Reported: 2026-05-07

SSR Mining's shares jumped 15.1% following a first quarter marked by better-than-expected free cash flow generation and strategic progress, notably the announced Copler divestment, which enhances the company’s financial flexibility and sharpens its Americas-focused asset base.

Key takeaways

Generated over $210 million in free cash flow in Q1, fueling a net cash position of $634 million with zero debt after convertible notes settlement.
Announced a $1.5 billion definitive agreement to sell the Copler mine, expected to close by Q3 2026, significantly reshaping the portfolio toward high-quality US assets.
Continued operational strength from Marigold and Cripple Creek & Victor (CC&V), with CC&V producing ~$325 million in free cash flow since acquisition in 2025, well exceeding purchase price.
Puna mine contributed strong site-level free cash flow of more than $120 million, reflecting its status as a top-tier, high-margin silver operation.
Completed $300 million in share repurchases post-quarter, representing disciplined capital allocation and a focus on shareholder value accretion.

SuRo Capital Corp.

SSSS Q1 2026

Reported: 2026-05-07

SuRo Capital’s shares edged up modestly by 1.1% following Q1 2026 results that demonstrated continued portfolio appreciation but lacked new catalysts to drive a stronger market move.

Key takeaways

Net asset value (NAV) rose 76% quarter-over-quarter to $14.24 per share, marking the largest quarterly gain in company history.
Portfolio highlights included major financings at premium valuations for WHOOP ($10.1B), OpenAI ($852B), VAST Data ($30B), and Canva ($42B), reflecting focus on AI and infrastructure.
New investments during the quarter and post-quarter included a staged funding commitment to TensorWave and a $10 million injection into ClickHouse, expanding exposure to AI-related infrastructure and data analytics.
Management emphasized disciplined capital deployment and selective participation aligned with long-term technology trends rather than broad market momentum.
Despite the NAV growth and strategic moves, the lack of upward market response above 3% suggests investors remain cautiously optimistic without perceiving a material change in near-term outlook or guidance.

Talos Energy Inc.

TALO Q1 2026

Reported: 2026-05-07

Shares of Talos Energy Inc. declined 6.3% following the earnings release, reflecting investor disappointment with cautious forward guidance and signs of deceleration in capital deployment flexibility despite steady operational execution.

Key takeaways

Q1 production reached approximately 89 thousand BOE/day, slightly above guidance, supported by 64 thousand barrels of oil per day and strong well productivity at Cardona.
Adjusted free cash flow was $113 million, underpinned by disciplined cost management and top-decile EBITDA margins driven by an oil-weighted portfolio and unit operating costs around $16/BOE.
Drilling and completion activities progressed efficiently, including the CPN well with zero completion-related nonproductive time; remediation at the Genovese well is slightly ahead of schedule.
Exploration efforts continue with recent seismic investments and lease awards adding prospects totaling over 300 million barrels of gross unrisked resource potential, but these remain early-stage and capital allocation is cautious.
Despite low operating costs and steady production, cautious tone on capital deployment and a modest outlook on near-term growth opportunities weighed on the stock.

TaskUs Inc. Class A Common Stock

TASK Q1 2026

Reported: 2026-05-07

TaskUs shares edged down 0.3% following a mixed quarter marked by decelerating growth from its largest client and early signs of revenue decline in its Trust and Safety segment despite solid performance in AI Services and overall margin expansion.

Key takeaways

Total revenue reached $306.3 million, up 10.3% year-over-year, slightly above the top end of guidance by about 3%.
Growth from the largest client slowed sharply to 1%, weighing on overall revenue concentration (down to 24%) due to continued automation efforts.
Trust and Safety revenue grew 4.7% year-over-year but is expected to decline starting Q2 and through full-year 2026.
AI Services, the fastest-growing segment, delivered a 36% revenue increase to $61.9 million, driven by clients in mobility, logistics, travel, robotics, and technology.
Adjusted EBITDA margin reached 19.1%, about 3.5% ahead of the top end of guidance, supported by operational efficiencies and refinancing.

Taboola.com Ltd. Ordinary Shares

TBLA Q1 2026

Reported: 2026-05-07

Taboola's shares surged 36.7% following a quarter that beat expectations across the board, driven by stronger-than-anticipated revenue growth, margin stability, and raised full-year guidance supported by its Realize platform's momentum.

Key takeaways

Revenue rose 9% year-over-year to $466.4 million, surpassing the high end of guidance.
The company raised full-year expectations for excess gross profit growth to 8%, while maintaining 30% adjusted EBITDA margins.
Realize platform continues to accelerate scaled advertiser counts (+3.5%) and average revenue per scaled advertiser (+5%), driving budget expansion.
Share repurchases remain a key capital allocation focus, with 19% of shares bought back since 2025.
Introduction of Realize+, an automated framework aimed at improving advertiser outcomes and simplifying campaign management, underlines product innovation and competitive positioning.

Bio-Techne Corporation

TECH Q3 2026

Reported: 2026-05-07

Bio-Techne’s shares fell 10.2% following the quarter, as investor disappointment centered on continued organic revenue deceleration driven by emerging biotech weakness and cautious near-term outlook despite some pockets of growth and margin improvement.

Key takeaways

Organic revenue declined 2% for the quarter, weighed down by high single-digit declines in emerging biotech spending.
Large pharma segment sustained low double-digit growth for its sixth consecutive quarter, while U.S. academia returned to low single-digit growth.
Adjusted operating margin improved sequentially by 310 basis points to 34.2%, reflecting disciplined cost management.
Order timing from two fast track cell therapy customers and a large OEM supply order created a 400 basis point headwind.
China market continued positive organic growth for the fourth quarter in a row, driven by demand in biopharma and CRO sectors.

Tempus AI, Inc. Class A Common Stock

TEM Q1 2026

Reported: 2026-05-07

Tempus AI’s shares dropped 4.1% following the earnings report, driven by cautious outlook signals despite solid revenue growth. Investor concerns likely centered on deceleration in hereditary diagnostics and tempered margin expectations implicit in the adjusted EBITDA guidance.

Key takeaways

Revenue of $348.1 million grew 36% year-over-year, supported by Oncology unit growth of ~28% and strong performance in solid tumor, liquid biopsies, and MRD volumes.
Hereditary diagnostics growth slowed significantly, attributed to difficult prior-year comparables, with expectations of mid-teen growth returning only in the second half of the year.
Data and applications revenue reached $87 million, up 40.5%, led by data licensing and modeling insights growing over 44%, with third consecutive quarter of bookings above $100 million.
Guidance was raised to $1.59-1.6 billion in revenue for the full year with adjusted EBITDA around $65 million, implying margin pressure and more cautious profitability targets.
Commentary highlighted solid large pharma collaborations, including new strategic deals with Merck and Gilead, yet did not fully offset investor wariness of growth pacing and margin trajectory.

Triple Flag Precious Metals Corp.

TFPM Q1 2026

Reported: 2026-05-07

Triple Flag’s shares rose 4.1% post-earnings, driven by record quarterly performance and accretive royalty acquisitions that underscore its growth trajectory and high-margin cash flow model.

Key takeaways

Q1 2026 delivered record metrics including over 30,000 GEOs, $129 million adjusted EBITDA, and $0.55 operating cash flow per share — all quarterly highs.
Operating cash flow per share grew 67% year-over-year, supporting the company’s progressive dividend policy and opportunistic share buybacks.
The recent $23 million acquisition of a 3% gross revenue royalty on the Gunnison Copper project enhances growth prospects in a strategic U.S. copper asset with substantial resource potential and infrastructure already in place.
Portfolio assets like Hope Bay, Beta Hunt, Fosterville, Arthur, and Northparkes are performing ahead of expectations, with expansions and development studies positioning the company well beyond 2030.
The balance sheet remains strong with $144 million cash, no debt, and over $1 billion liquidity, providing flexibility for continued capital deployment.

Talen Energy Corporation

TLN Q1 2026

Reported: 2026-05-07

The stock jumped 6.6% following the report, reflecting investor approval of the company's operational resilience during winter, accretive acquisitions, and an upward revision in 2027 and 2028 free cash flow outlooks that imply attractive valuations.

Key takeaways

Delivered $473 million adjusted EBITDA and $350 million adjusted free cash flow in Q1, demonstrating growth driven by recent acquisitions and improved operations.
Winter operations were notably strong, with efficient outage management at Susquehanna and fleet capacity factor reaching 55%.
Signed and financed the Cornerstone acquisition, expected to close this summer, which will further enhance free cash flow per share.
Reaffirmed 2026 guidance excluding Cornerstone assets, while providing preliminary 2027 and 2028 outlooks showing significant free cash flow growth and improved financing costs.
Market conditions remain tight with rising spark spreads supporting higher dispatch of flexible assets, though localized transmission issues create some basis volatility.

TransMedics Group, Inc.

TMDX Q1 2026

Reported: 2026-05-07

Shares dropped 24.9% following the earnings release as investors were clearly disappointed by the cautious outlook and enrollment delays in critical clinical programs, which suggest a deceleration in near-term growth drivers despite solid revenue growth.

Key takeaways

Total revenue grew 21% year-over-year to $174 million, with U.S. transplant product revenue up 22% and OUS transplant revenue increasing 39%.
Adjusted operating profit reached $18.1 million, or 10.4% of revenue, reflecting ongoing heavy investment in growth initiatives.
Enrollment delays in the ENHANCE and DENOVO clinical programs due to competitive reactions have postponed anticipated contributions from these key cardiothoracic growth drivers.
Introduction of the CHOPS device aims to address clinical trial enrollment challenges and expand the product portfolio, but regulatory clearance is still pending.
Despite operational progress, the market reacted negatively, signaling concerns over near-term growth sustainability and cautious outlook from management.

Trinity Capital Inc.

TRIN Q1 2026

Reported: 2026-05-07

Trinity Capital Inc.'s shares were largely unchanged following Q1 results as investors digested steady asset growth and credit metrics without major surprises. The muted 0.3% stock move reflects a balanced view on consistent originations and disciplined underwriting amid no clear catalysts to move the stock.

Key takeaways

Net asset value increased 7% quarter-over-quarter to a record $1.2 billion, supporting firm capital growth.
Platform AUM grew 36% year-over-year to over $2.9 billion, reflecting continued scale expansion.
Fundings totaled $306 million in Q1, marking a 39% increase from 2025, underlining stable origination activity.
Nonaccruals remained low at 1% of portfolio fair value, indicating steady credit performance.
Managed funds platform contributed $0.04 to net investment income per share of $0.53, demonstrating incremental income diversification.

Trimble Inc.

TRMB Q1 2026

Reported: 2026-05-07

Trimble’s shares dropped 9.5% after earnings as investors reacted negatively to an implied cautious outlook and lack of incremental margin expansion despite solid top-line growth and ARR increases.

Key takeaways

Revenue grew 12% year-over-year to $940 million, with ARR up 13% to $2.435 billion, reflecting ongoing customer adoption.
EPS of $0.79 came in above the high end of the company’s range, though margin commentary suggested limited upside.
AECO segment posted 14% growth in both revenue and ARR, expanding in Asia Pacific and Europe alongside North America.
The company highlighted strategic AI integrations like SketchUp with Anthropic’s Claude and new AI-driven contract risk management capabilities via the Document Crunch acquisition.
Despite growth and innovation efforts, the broad market reaction indicates skepticism around sustainability of margins and the trajectory of growth beyond these initial AI-driven initiatives.

Uber Technologies, Inc.

UBER Q1 2026

Reported: 2026-05-07

Uber's 5.2% stock gain reflects upside surprises in growth acceleration, margin expansion, and profitability, driven by strong execution in Mobility and Delivery alongside robust audience growth and innovative product launches.

Key takeaways

Gross bookings rose 21% year-over-year, propelled by 20% growth in Mobility with record margins, and 23% growth in Delivery, notably from grocery and retail segments.
Uber One membership surpassed 50 million, growing 50%, with members showing triple the spending and higher retention, underpinning strong cross-platform engagement.
Non-GAAP EPS surged 44% year-over-year, outpacing bookings growth through disciplined cost control and operating leverage.
Freight returned to growth after nearly two years of decline, indicating broad-based strength across segments.
Uber launched expanded travel-related services, including hotel bookings via a partnership with Expedia, extending the move from on-demand rides to planned reservations, which could unlock new revenue streams.

Unicaja Banco, S.A.

UNI.MC Q1 2026

Reported: 2026-05-07

Shares rose 3.0% following first quarter results that showed accelerating growth in key business volumes, steady asset quality, and uplifted shareholder remuneration targets, all of which appeared to pleasantly surprise investors amidst ongoing uncertainty.

Key takeaways

Business volumes accelerated to over 3% year-on-year, driven by nearly 4% growth in customer funds and an 11% increase in off-balance sheet funds, primarily mutual funds with 17% growth.
Performing loans grew 2.4% year-on-year, fueled by positive momentum in mortgages, SME loans, and consumer lending segments.
Net income reached EUR 161 million, supported by higher net interest income and fees, combined with lower provisions offsetting a mid-single-digit increase in costs.
Asset quality remained robust with net NPA ratio at 0.7%, NPL ratio down to 2%, coverage improved to 80%, and cost of risk decreasing to 20 basis points, below initial guidance.
Capital position remained stable with CET1 at 16%, enabling a raised dividend payout target up to 95% of net income and resulting in an attractive 9% dividend yield.

Upstart Holdings, Inc.

UPST Q1 2026

Reported: 2026-05-07

Upstart’s shares fell 10.5% after the company signaled margin compression and a cautious outlook amid strong originations growth, disappointing investors who had expected sustained profitability improvement.

Key takeaways

Originations grew 61% year-over-year, driven by strong performance in auto (+300% YoY) and home loans (+250% YoY).
Revenue rose 44% YoY; however, profit declined marginally, reflecting margin pressure and planned investments.
The company emphasized expanding AI capabilities and product innovation but acknowledged seasonal and investment-related headwinds in Q1.
Management highlighted progress in new products like Cash Line but indicated a strategic shift toward improving unit economics, suggesting a more cautious outlook.
Despite solid top-line growth, investors reacted negatively, likely due to weakening margins and reservations about near-term profitability.

United Therapeutics Corporation

UTHR Q1 2026

Reported: 2026-05-07

United Therapeutics shares declined modestly by 0.5% following the earnings update, reflecting cautious investor response despite continued product development progress and clinical trial successes. The market appears unmoved by management’s optimistic pipeline commentary amid the absence of updated financial guidance or clear near-term revenue drivers.

Key takeaways

Management highlighted two Phase III trial successes for ralinepag (PAH) and Tyvaso (IPF), positioning them as transformative therapies with potential to double revenue run rate by 2027 to $4 billion.
Ralinepag demonstrated a threefold reduction in disease progression in PAH with durable, superior hazard ratios versus competitors, while Tyvaso showed improved FVC benefits in IPF patients.
The company announced early stage development of RALDPI, an inhaled ralinepag formulation, expected to significantly expand patient reach across PAH, ILD, IPF, and PPF indications.
No updated financial guidance or concrete near-term commercial metrics were provided; the narrative was heavily forward-looking and pipeline-focused without addressing margin trends or current market challenges.
Production capacity expansion efforts in Connecticut and North Carolina were noted to support expected DPI demand, but specifics on timing or revenue impact remain vague.

Universal Technical Institute, Inc.

UTI Q2 2026

Reported: 2026-05-07

Shares dropped 8.1% following earnings as investors reacted negatively to cautious outlook signals and margin pressures, despite steady revenue growth and student enrollment gains.

Key takeaways

Revenue rose nearly 7% year-over-year to $221 million, driven by 14% growth in new student starts across UTI and Concorde divisions.
Average full-time active students increased 7%, indicating ongoing demand momentum.
Adjusted EBITDA of $25 million included $11 million in growth investments, with reported adjusted EBITDA just over $14 million, highlighting margin compression from increased spending.
Management reaffirmed full-year guidance but emphasized execution risks tied to new campus openings and program launches.
Early campus launches showed encouraging enrollment pacing, yet investors remain cautious on scaling projections and profitability timelines.

Veracyte, Inc.

VCYT Q1 2026

Reported: 2026-05-07

Shares surged 23.1% reflecting investor enthusiasm driven by stronger-than-expected volume growth in Decipher tests, advancing clinical catalysts, and improving profitability metrics.

Key takeaways

Decipher test volume rose 24% year-over-year to approximately 28,000 tests in Q1, driven by expanded provider adoption and higher orders per physician.
Growth was particularly strong in high-risk prostate cancer categories, with nearly 30% volume increase in advanced disease segments.
Multiple late-stage clinical trials (including GUIDANCE and ENZAMET) advancing, supporting Decipher’s potential as a treatment decision biomarker.
Adjusted EBITDA margin exceeded expectations, reflecting ongoing operational efficiency improvements.
Upcoming product launches (Prosigna LDT and TrueMRD) represent important growth levers to extend the platform and address new clinical settings.

Versigent PLC

VGNT Q1 2026

Reported: 2026-05-07

Versigent's shares gained 4.0% following its debut quarter as a public company, driven by evidence of solid execution in program launches, new customer wins, and strong quality and delivery metrics that supported confidence in its growth trajectory and margin potential.

Key takeaways

Generated nearly $9 billion in annualized revenue as a standalone business, leveraging scale from its Aptiv carve-out.
Delivered multiple complex, high-content vehicle program launches globally with over 99% quality and on-time delivery.
Secured new program wins and extensions with leading OEMs across regions, highlighting sustained demand for advanced low- and high-voltage architectures.
Progressed selectively in non-automotive markets, applying core capabilities without altering its disciplined operating model.
Emphasized strategic priorities around cost optimization, automation, and disciplined capital allocation to drive long-term shareholder value.

Veolia Environnement S.A.

VIE.PA Q1 2026

Reported: 2026-05-07

Veolia’s shares were largely unchanged after reporting Q1 results showing modest revenue growth and margin expansion, reflecting steady but unspectacular execution amid ongoing geopolitical challenges and some delays in project signings.

Key takeaways

Revenue increased 2.1% at constant scope and forex (excluding energy prices) to EUR 11.4 billion, showing stable demand despite a tough macro environment.
EBITDA rose 5.1% on a constant basis and 5.8% including tuck-in acquisitions, driven by margin improvement of 73 basis points to 15.5%.
Current EBIT grew 7.2%, signaling operational leverage, while net free cash flow improved by EUR 144 million vs. prior year.
Growth was led by strong performances outside Europe (+3.1%) and in the U.S. (+7.5%), despite some impact from cold weather on hazardous waste volumes.
Water Technologies segment was resilient, though project signings were delayed due to Middle East tensions; France Hazardous Waste saw some weather-related weakness expected to reverse.

Viemed Healthcare, Inc.

VMD Q1 2026

Reported: 2026-05-07

Shares declined 5.1% following a cautious outlook on the ventilation segment driven by near-term patient census pressure due to new compliance requirements. Despite solid growth in sleep and maternal health, investors appear concerned about margin and growth headwinds embedded in the ventilation dynamics.

Key takeaways

Revenue grew 28% year over year to $75.4 million, largely driven by a 57% increase in PAP therapy patients, now totaling nearly 36,000.
Maternal health expanded beyond legacy markets with just under 4,000 new patients served, demonstrating scalable platform leverage.
Ventilation patient census declined to 12,089 due to higher turnover driven by stricter compliance evaluation points under new Medicare coverage determination (NCD) rules—cited as a near-term headwind rather than a demand issue.
Compliance among active ventilator patients has improved nearly 20% since NCD implementation, indicating some operational progress but ongoing challenges remain.
Management acknowledged inherent risks in compliance framework, which can lead to interruptions in life-sustaining therapy access; this regulatory uncertainty and operational complexity likely weighed on investor sentiment.

Voya Financial, Inc.

VOYA Q1 2026

Reported: 2026-05-07

Shares fell 4.1% post-earnings as investors reacted to cautious flow trends and a timing-driven net inflow in Retirement, alongside margin pressure signals in Investment Management that may have tempered confidence in near-term growth.

Key takeaways

Adjusted operating EPS grew 13% year-over-year to $2.26 in Q1, reflecting solid execution across segments.
Retirement segment reported $209 million in adjusted operating earnings, up 14% year-over-year, with margins holding at 39%, though first-quarter net inflows were timing-driven and below expectations.
Investment Management adjusted operating earnings rose 12% to $46 million, with margins at 28.6%, supported by higher institutional and retail fees; however, investor caution likely arises from cautious outlook around flows and margin sustainability.
Employee Benefits delivered improved earnings through disciplined underwriting and pricing, particularly in Stop Loss, targeting full margin recovery.
Generated approximately $200 million of excess capital returned via shareholder distributions, maintaining capital discipline amid an uncertain outlook.

Voyager Technologies, Inc.

VOYG Q1 2026

Reported: 2026-05-07

Voyager’s 4.1% post-earnings stock gain was driven by stronger-than-expected bookings and a raised full-year revenue guidance, signaling investor approval of accelerating demand and backlog expansion.

Key takeaways

Bookings reached $45 million in Q1, driving backlog to a record $275 million, a 54% increase year-over-year.
Book-to-bill ratio stood at 1.3, indicating sustained demand exceeding current revenue.
Full-year 2026 revenue guidance was raised to $230 million–$255 million, reflecting confidence in conversion of backlog to sales.
Continued capacity investments include expansion of the Voyager American Defense Complex and the new Space Beach facility to support higher production volumes.
Innovation spend hit a record 48% of revenue, reflecting heavy investment in next-generation defense and space technologies, as well as AI-driven manufacturing acceleration.

Warner Bros. Discovery Inc. Series A Common Stock

WBD Q1 2026

Reported: 2026-05-07

Warner Bros. Discovery’s shares edged down 0.4% following Q1 2026 results as investors appeared to weigh progress in subscriber growth and content launches against limited margin commentary and cautious forward outlook signals.

Key takeaways

HBO Max successfully launched in the U.K., Germany, Italy, and Ireland, expanding its global footprint beyond reliance on Sky licensing.
Total subscribers surpassed 140 million by quarter-end, ahead of prior guidance, with plans to exceed 150 million by year-end.
Viewer engagement remains strong with flagship series like *The Pitt* (20M viewers/episode) and *A Knight of the Seven Kingdoms* (36M viewers/episode).
Management projects accelerating subscriber-related revenue growth throughout the year, though quantification and margin impact remain unclear.
The quarter’s solid content slate and studio momentum contrast with the mildly negative stock reaction suggesting investor reservations about pace of profitability or broader strategic execution.

Wallbox N.V. Class A Ordinary Shares

WBX Q1 2026

Reported: 2026-05-07

Wallbox's stock rose 4.8% following the Q1 report, driven by operational efficiency improvements and adjusted EBITDA gains despite weaker-than-expected revenue and lower DC sales that pressured margins and guidance.

Key takeaways

Q1 revenue declined 12% quarter-over-quarter to EUR 29.7 million, missing guidance primarily due to a 28% drop in DC charger sales linked to refinancing-related customer uncertainty.
Gross margin of 37.3% fell short of the 38–40% guidance range, reflecting an unfavorable product mix caused by lower DC sales.
Operating expenses improved significantly, with labor cost and overhead down 22% sequentially and 31% year-over-year, reflecting ongoing efficiency efforts and resource shifts.
Adjusted EBITDA loss narrowed by 18% sequentially and 23% year-over-year to EUR -6 million, missing guidance but demonstrating progress on operational profitability.
Geographic weakness was evident in North America (down 41% year-over-year) due to soft EV market conditions, while Europe saw an 8% sequential revenue decline in line with broader market contraction.

GeneDx Holdings Corp. Class A Common Stock

WGS Q1 2026

Reported: 2026-05-07

Shares plunged 47.2% following GeneDx Holdings' earnings release, driven by a significant revenue shortfall mainly due to lower-than-expected reimbursement rates and underperformance in non-core businesses, prompting a downward revision of full-year guidance.

Key takeaways

Q1 test volume grew 34% year-over-year, indicating strong market demand and early growth in expansion markets.
Total revenue missed expectations by $12 million, attributed to a $5.5 million shortfall from lower blended average reimbursement rates and a $6.5 million shortfall in non-core businesses.
Full-year revenue guidance was lowered to a range of $475 million to $490 million, reflecting ongoing challenges in reimbursement and softer contributions from Fabric and biopharma segments.
Gross margins are expected to hold near 70%, with commitments to return to adjusted profitability in 2026 and significant profitability growth anticipated in 2027.
The company is focusing resources on core diagnostic offerings and international expansion of the Fabric business, while biopharma sales cycles remain elongated, delaying expected revenue ramp.

Westlake Chemical Partners LP

WLKP Q1 2026

Reported: 2026-05-07

Westlake Chemical Partners shares rose 3.4% following first quarter results that showcased stable fee-based cash flow and an improved coverage ratio, reflecting better-than-expected operational consistency amid ongoing geopolitical supply disruptions.

Key takeaways

First quarter net income was $14 million, or $0.40 per unit, with distributable cash flow of $18 million, or $0.51 per unit.
Sequential net income declined slightly versus Q4 2025 due to lower volumes but was largely offset by higher third-party prices.
Trailing 12-month distribution coverage ratio improved to 1.0x from 0.8x, marking an operating surplus and aging out of last year’s Petro 1 turnaround impact.
Capital expenditures totaled $6 million at OpCo in Q1, with no planned turnarounds for 2026 supporting stable operations.
Management acknowledged ongoing Middle East-related supply disruptions driving North American demand, underpinning fee-based cash flow stability.

The Williams Companies, Inc.

WMB Q1 2026

Reported: 2026-05-07

Williams' shares declined 2.2% following mixed first-quarter results marked by margin pressures and a cautious full-year outlook, tempering enthusiasm despite ongoing project execution and backlog growth.

Key takeaways

Q1 adjusted EBITDA grew 13% year-over-year to a record $2.25 billion, driven primarily by strong performance in Transmission and Gulf businesses.
Transmission and Gulf segments contributed nearly $150 million in incremental EBITDA, led by a 10% rise in Transco and a 60%+ increase in Deepwater Gulf operations.
Natural gas storage and West segments expanded 35% and 16% respectively, with notable contributions from Haynesville and Louisiana Energy Gateway Pipeline assets.
Northeast Gathering & Processing showed modest 2% growth as gains in rich gas regions were offset by volume declines in dry gas areas.
Management projects full-year EBITDA in the upper half of guidance range but refrains from raising targets, reflecting a more cautious outlook amid complex market dynamics.

Wolfspeed Inc. Common Stock

WOLF Q3 2026

Reported: 2026-05-07

Wolfspeed’s shares jumped nearly 20% post-earnings, reflecting strong momentum in AI-related product growth and clear progress in advancing technology leadership and operational initiatives.

Key takeaways

Revenue of $150 million came in at the midpoint of guidance, indicating stable top-line performance.
AI data center applications grew approximately 30% sequentially, highlighting accelerating demand in a key end market.
Introduced the industry’s first commercially available 10-kilovolt silicon carbide power MOSFET, expanding leadership in high-voltage applications.
Completed planned shutdown of 150-millimeter device production, improving operational efficiency and preparing for 300-millimeter platform scale-up.
Refinanced senior secured notes, showing proactive financial discipline and investor confidence in long-term growth prospects.

XPEL, Inc.

XPEL Q1 2026

Reported: 2026-05-07

XPEL's stock fell 11% following earnings as investors likely reacted negatively to softer than expected near-term guidance and cautious commentary on the macro outlook, despite strong water infrastructure growth and record margins.

Key takeaways

Water infrastructure segment revenue rose 19% year-over-year to a record ~$97 million, with gross margins before D&A reaching a new high above 30% consolidated and 56% segment level.
The company added multiple new contracts, including MVCs and acreage dedications, expanding footprint across key basins with limited capital required.
Recent acquisitions in the Northern Delaware Basin added disposal capacity, water rights, and storage, expected to drive future growth.
Water services segment grew 7% quarter-over-quarter, supported by strong demand in chemical technology products, with anticipated double-digit revenue and margin growth in Q2.
Management flagged uncertainty around commodity markets and geopolitical risks, indicating a cautious stance despite potential upside from higher skim oil pricing and a stable U.S. energy industry outlook.

Clear Secure, Inc.

YOU Q1 2026

Reported: 2026-05-07

CLEAR’s shares declined 1.0% following Q1 results as growth momentum in bookings and memberships showed signs of slowing, and management’s cautious outlook tempered enthusiasm despite solid financial execution.

Key takeaways

Bookings rose 40.8% year-over-year to $292 million, with revenue up 19.7% to $253 million.
Active CLEAR+ members increased 13% to 8.2 million, driven by improved retention and eGate adoption.
Adjusted EBITDA margins expanded to approximately 32%, complementing a doubling of free cash flow to $185 million.
Management noted structural challenges in travel and rising AI-driven fraud, signaling a complex operating environment ahead.
Though execution remains strong, the momentum appears to have decelerated during the quarter, aligning with a more cautious outlook.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.